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Novel Roles for B-Raf in Mitosis and Cancer  
Meghan E. K. Borysova 
ABSTRACT 
 
The MAP kinase pathway is well known for its key roles in regulating cell 
proliferation and cell cycle progression.   MAP kinases have also been implicated in 
mitotic functions, however these functions are less-well understood.  Recent studies from 
our laboratory used Xenopus egg extracts to identify B-Raf as an essential activator of the 
MAPK cascade during mitosis.  Therefore, the first objective of my dissertation research 
was to determine if B-Raf has functional significance during mitosis in human somatic 
cells.   
 Using RNA interference against B-Raf and various immunofluorescence 
techniques, I show that B-Raf:  (1) localizes to and is phosphorylated at a key mitotic 
structure, (2) is critical for proper mitotic spindle assembly and chromatin congression, 
(3) is important for the engagement of microtubules with kinetochores during mitosis, 
and (4) is necessary for activation of the spindle assembly checkpoint.  
It has been demonstrated that B-Raf is a prominent oncogene, constitutively 
activated in the vast majority of melanomas and other cancers.  I hypothesized that 
oncogenic B-Raf expression perturbs mitosis and causes aneuploidy.   
First, we show that oncogenic B-Raf expression correlates with mitotic 
abnormalities in human melanoma cells and that spindle defects are induced when 
xii 
oncogenic B-Raf is ectopically expressed.  Further, using FISH and karyotype analysis, I 
demonstrate that oncogenic B-Raf drives aneuploidy and chromosome instability in 
primary, immortalized, and tumor cells.   
In summary, my dissertation studies elucidate novel roles for B-Raf in 
mammalian mitosis.  In addition, my studies show for the first time that oncogenic B-Raf 
disrupts mitosis causing chromosomal instability.  I propose that oncogenic B-Raf-
induced chromosome instability contributes to tumorigenesis. 
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CHAPTER 1 
BACKGROUND AND INTRODUCTION 
 
Mitosis 
 The cell cycle is the order of processes by which a cell duplicates and divides its 
DNA equally into two identical daughter cells.  The cell cycle consists of temporally 
coordinated interphase (G1, S, G2 phases) and mitosis (prophase, metaphase, anaphase 
and telophase).  During interphase cells prepare for mitosis through cell growth, DNA 
duplication and nutrient accumulation.  Mitosis is the ultimate stage in the cell cycle 
during which the cell partitions its chromosomes and subsequently divides its 
cytoplasmic components into two identical and distinct daughter cells.   
 
Stages of Mitosis 
 Mitosis is an irreversible process whose stages have traditionally been described 
by gross structural and behavior changes documented by light microscopists.  Modern 
use of fluorescence microscopy has aided in the identification of mitotic stages (Fig. 1).  
Proteins and enzymatic activities which regulate these morphological changes and their 
transitions serve as biochemical markers for some of the mitotic phases.  
 Entry into mitosis directly follows the latter part of the second gap (G2) phase 
during which cells can be reversibly arrested in response to various stresses [1].  Passage 
through late G2 serves as a ‘point of no return’ and marks the termination of interphase 
  
 
 
 
 
 
 
 
        
Interphase Prophase Metaphase Anaphase Telophase 
Figure. 1  Stages of mitosis 
a.  Interphase cells have polymerized microtubules, and the decondensed chromatin resides within the nucleus surrounded 
by a nuclear membrane.  b.  Prophase is the first stage of mitosis; microtubules are depolymerized from their interphase 
stage, the DNA begins to condense, the nuclear envelope is broken down and the two centrosomes migrate to opposite 
poles.  c.  During metaphase,  condensed chromosomes align at the metaphase plate and the bipolar spindle is formed.  d.  
In anaphase, the spindle pulls the chromosomes in a poleward directions.  e.  During telophase/cytokinesis, the DNA is 
partitioned into two distinct regions, the nuclear envelopes reform and the cell pinches off into two daughter cells. 
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and the beginning of mitosis.  The phases of mitosis are most frequently referred to as 
prophase, prometaphase and metaphase – the stages of early mitosis; and anaphase and 
telophase - the phases of mitotic exit.   
 Prophase is the initiating stage of mitosis.  It is traditionally defined as the point at 
which condensing chromosomes are first visible in the membrane-bound nucleus when 
observed by light or fluorescence microscopy.  As well during prophase, the two 
centrosomes (the mother centrosome is duplicated during S-phase) move to opposite 
poles of the cell [2] where they initiate microtubule nucleation into focal arrays called 
asters[3].  Centrosomes and asters are visible via fluorescence microscopy.  Prophase is 
accompanied by the nuclear accumulation and activation of cyclin B-Cdk1 (also termed 
M-phase promoting factor, MPF), the master regulator of mitosis [4-9].  Cyclin B-Cdk1 
remains active throughout prophase, prometaphase and metaphase and, therefore, serves 
as a biochemical marker of early mitosis.  It has been shown that Cyclin B-Cdk1 
regulates chromosome condensation through direct phosphorylation of the condensin 
complexes [10-12].  Estimates reveal that DNA is compacted 1000-2000 fold over 
interphase chromosomes [13] and chromosome condensation is generally completed 
during prophase.  The significance of prophase events cannot be understated.  
Chromosomes condensation reveals the centromeres upon which the attachment sites for 
spindle microtubules are assembled.  Centrosome segregation is crucial for the 
organization of a bipolar spindle.  Aster formation serves to properly position the mitotic 
spindle.  Prophase ends and prometaphase is initiated when nuclear envelope breakdown 
become visible by light microscopy.  Nuclear envelope breakdown is largely a 
consequence of phosphorylation of nuclear lamins by the Cyclin B-Cdk1 complex [14].  
 4 
The nuclear membrane fragments into small vesicles which are eventually fuse during 
telophase to form the new intact nuclei.  Breakdown of the nuclear envelope permits the 
chromosomes to physically associate with the polymerizing microtubules.  Each 
chromosome has two sister kinetochores, one on each of the fused sister chromatids.   
During prometaphase kinetochores attach to the microtubules emanating from both poles 
of the developing spindle [15].  A spindle checkpoint arrest prevents anaphase onset until 
all kinetochores are fully engaged [16].  Following full engagement, kinetochore 
associated motor proteins direct the movement of attached chromosomes toward the 
spindle poles.  Spindle microtubule growth acts as an opposing force that pulls the 
chromosomes toward the center of the mitotic spindle [17].  Eventually the forces balance 
thus aligning the chromosomes at the spindle equator, called the metaphase plate.  It is at 
this point of chromosome congression that the cell has entered metaphase. 
 During metaphase chromosomes are aligned at the equator of an organized, fully 
formed, bipolar spindle (Fig. 2).  Cyclin B-Cdk1 remains active during metaphase.  Sister 
chromatids remain fused by cohesin complexes at the region of the centromere [18-20].    
 Metaphase ends and anaphase is initiated when sister chromatids are disjoined.   
Sister chromatid segregation results from the abrupt and synchronous degradation of the 
cohesin molecules that hold them together [21-23].  The onset of anaphase occurs when 
the anaphase promoting complex/cyclosome (APC/C) becomes active.  APC/C is an E3 
ubiquitin ligase which targets a number of mitotic substrates including securin and Cyclin 
B, for proteasome mediated destruction [24].  The destruction of securin allows for the 
activation of separase which subsequently cleaves the cohesin molecules [25].  After the 
dissolution of cohesin, kinetochore microtubules begin to shorten and kinetochore forces 
  
 
 
 
 
 
 Figure. 2  The mitotic spindle The bipolar spindle apparatus formed during mitosis has several 
key features:  a.  microtubules polymerize from the centrosomes 
to the kinetochores; b.  the kinetochores are a proteinaceous 
structure to which the microtubules attach; c.  the centrosomes  
are the microtubule organizing center (MTOC) of mammalian 
cells.  
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result in poleward movement of the chromatids.  This movement is detectable by light 
microscopy and is termed early anaphase or ‘anaphase A’ which culminates when the 
chromatids reach the poles.  Late anaphase or ‘anaphase B’ then ensues during which 
time poleward microtubules elongate thus the entire spindle elongates, thereby 
partitioning the chromatids further apart [15].  Rapid degradation of cyclin B is the most 
commonly used biochemical marker for anaphase and leads to the hallmarks of telophase.   
 Telophase is the final stage of mitosis during which the chromosomes and 
cytoplasm are ultimately divided [15].  It is during this stage that the nuclear envelopes 
reform around both sets of chromosomes, the chromosomes decondense, the 
microtubules return to an interphase state and the cell is divided into two daughter cells.  
All of these features are detectable through light and fluorescence microscopy.  It is due 
to the destruction of cyclin B-Cdk1 that components of the nuclear envelope and 
chromosomes no longer undergo phosphorylation, thereby permitting the reformation of 
the envelope and decondensation of chromosomes.  Simultaneously, an actin-myosin 
contractile ring positioned beneath the plasma membrane causes the membrane to 
invaginate at the former site of the metaphase plate creating a cleavage furrow in the 
cytoplasm.  Following nuclear envelope reformation, the contractile ring pinches the cell 
in half at the furrow, thus allowing for the equal separation of the cytoplasm, a process 
termed cytokinesis.  The completion of cytokinesis gives rise to two daughter cells both 
of which are in the beginning stage of interphase.   
 
 
 
 7 
Organization of the Mitotic Spindle 
 The mitotic spindle is the structural and functional unit of the cell that is 
responsible for the mitotic partitioning the duplicated chromosome pairs.  While the 
structure of the spindle apparatus changes continually throughout mitosis, the 
quintessential metaphase spindle is fusiform - elliptical in shape, having tapered spindle 
poles and a wide midzone.  The basic elements of the mitotic spindle are the centrosomes 
and the microtubules (Fig. 2).  While not primary components of the spindle, 
chromosomes and kinetochores are necessary for the structural formation of the spindle 
apparatus. 
 The spindle poles serve as the microtubule organizing centers (MTOC) that 
initiate the formation of the mitotic spindle.  In animal cells, the MTOCs are 
centrosomes, organelles containing a pair of orthogonally arranged centrioles surrounded 
by protein rich pericentriolar material, including pericentrin, ninein, γ-tubulin and others 
[26-29].  The single centrosome of the cell is duplicated during S-phase.  Early in mitosis, 
Nek2 kinase promotes the migration of the two centrosomes to opposite poles of the cell 
[30-33].  γ-tubulin and other members of the gamma complex protein family form 
hundreds of ring-shaped γ-tubulin ring complexes per centrosome (γ-TuRC).  γ-tubulin is 
required for microtubule nucleation [34, 35] and, while the exact mechanism is not 
completely understood, γ-TuRCs are most likely the sites of microtubule nucleation [36-
38]. 
 Microtubule polymers are composed of α- and β-tubulin dimers whose orientation 
in the polymerized microtubule gives microtubules their polarity.  The opposing ends of 
microtubules have different tubulin-polymerizing properties and orientations in the 
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mitotic spindle. The relatively static minus ends of the microtubules interact with the 
pericentriolar material of the centrosome and the highly dynamic plus ends extend away 
from the centrosome [39, 40].  These intrinsic features of polarity and dynamic instability 
are what give the microtubules the ability to form the mitotic spindle.   
At least three types of microtubules comprise the mitotic spindle, all of which 
emanate from the MTOC.  Astral microtubules are organized in radial arrays around both 
centrosomes.  They connect the spindle poles to the cortex of a mitotic cell, thus, are 
critical for proper positioning of the mitotic spindle and mark the site for subsequent cell 
division [41].  Interpolar microtubules polymerize toward the poles opposite of their 
nucleation.  They terminate in the body of the spindle where some of them interact with 
the plus ends of antiparallel interpolar microtubules thus giving the spindle stability [42].  
During late anaphase, the interpolar microtubules polymerize and slide thereby 
elongating the spindle.  Finally, the plus ends of kinetochore fibers (K-fiber), comprised 
of 20-30 microtubules [43, 44], associate with, and are captured by, the outer 
kinetochores of the chromosomes, thus connecting the chromosomes to the mitotic 
spindle [41, 45].  During early anaphase, the kinetochore microtubules shorten forcing 
the attached chromosomes to move in the direction of the spindle poles.    
 The centromeres of the chromosomes are specific regions of repetitive DNA 
sequences, which are critical for proper organization of the mitotic spindle.  First, they 
are the site of fusion between the chromatids thus creating a visible constriction site in 
metaphase chromosomes.  Secondly, they are also the sites where two identical 
proteinaceous structures called the kinetochores assemble and function.  Kinetochores 
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serve as the sites of microtubule engagement as well as the location of the spindle 
assembly checkpoint.  
 Accurate positioning and function of the centrosomes, microtubules and 
chromosomes are necessary for the proper formation of the metaphase spindle.  A 
properly formed spindle is fusiform in structure with sister chromatids bioriented and 
symmetrically arranged at the spindle equator.  Achieving this arrangement prior to 
anaphase is critical in order to ensure equal segregation of chromosomes, thereby 
maintaining the genomic integrity of both daughter cells.   
 
Spindle Assembly Checkpoint 
 In order to prevent chromosomal missegregation from occurring, anaphase must 
not proceed until all kinetochores are engaged in an amphitelic (bipolar) fashion.  A 
cellular surveillance mechanism called the spindle assembly checkpoint (SAC) ensures 
that anaphase onset is delayed until all chromosomes have achieved bipolar attachments.  
[16, 46, 47].   
 The process by which kinetochores capture K-fibers is largely a stochastic event 
based on their own chance interactions.  In brief, one sister kinetochore becomes engaged 
with K-fibers of the spindle, generating a monotelic chromosomal attachment.  
Subsequently the second sister kinetochore captures microtubules from the opposite pole 
and the chromosome becomes bioriented.  This somewhat random process can result in 
syntelic attachments where K-fibers from one pole engage with both sister kinetochores.  
As well, merotelic attachments can take place in which case K-fibers from opposite poles 
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engage with one sister kinetochore.  Therefore, monotelic attachments occur as a 
transitional state prior to achievement of bipolar engagement [48]. 
 Syntelic kinetochore-microtubule attachments cause chromosomes to be 
positioned near one pole and such attachments elicits the SAC [49].  Merotelic 
attachments are bipolar by definition, cause chromosomes to align at the metaphase plate 
and do not elicit a SAC.  The mechanism by which the syntelic chromosome orientation 
is reversed is not understood.  However, it has been proposed that Aurora B kinase is 
instrumental in reversing maloriented attachments [50-54] by phosphorylating targets that 
cause rapid microtubule turn-over at the kinetochores [55], after which amphitelic 
attachments are free to take place. 
 On the biochemical level the metaphase-anaphase transition is driven by the E3 
ubiquitin ligase activity of the APC/C which targets securin and cyclin B for proteasomal 
degradation.  The SAC functions as a sensory mechanism by detecting unattached 
kinetochores and as an effector by inhibiting the activation of the anaphase promoting 
complex/cyclosome (APC/C) (Fig. 3).   The nature of the ‘wait anaphase’ signal is not 
completely understood.  However, it is widely accepted that the SAC protein complexes 
assembled at unattached kinetochores early in mitosis and negatively regulate activation 
of the APC/C, thus preventing anaphase onset [56-60].     
 A large complex of proteins including Mad1, Mad2, BubR1, Bub1, Bub3, Mps1 
and Aurora B, comprise the core spindle checkpoint proteins in yeast [61-64] and 
mammalian cells [65-67].  It is evident that the proteins of SAC require kinetochore 
localization and function as large multi-componential protein complexes.   
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Aurora B [68-70] and Mps1 [71-73] are required for recruitment and localization 
of all other checkpoint proteins to the kinetochores.  The current model for SAC activity 
suggests that kinetochore bound Mad1 and Mad2 form a complex which can then bind 
Cdc20, the activator of APC/C [74-78] and the key target of the SAC [79].  However, 
Cdc20 binding by the Mad1-Mad2 complex is insufficient for inactivating APC/C.  
BubR1/Mad3 and Bub3 are all required for full inhibition of the APC/C [80, 81]. The 
BubR1 complex appears to synergize [59] with the Mad1-Mad2-Cdc20 complex by 
forming a supercomplex that can fully inhibit the APC/C.   
 Several other proteins have been shown to be involved in the SAC, including the 
ROD-SWILCH complex [82], p31 [83-85], cyclin B-Cdk1 [86, 87], NEK2 [88] and polo-
like kinase-1 (PLK1) [89].  The contribution of these proteins to the SAC is not well 
understood.   
   The activity of the spindle assembly checkpoint is essential for preventing 
chromosome missegregation and aneuploidy [90, 91].  The presence of a single 
unattached kinetochore is sufficient to activate the SAC and the SAC is not turned off 
until every kinetochore has formed fully saturated (25-30 microtubules) bipolar 
microtubule attachments.     
 
  
Fig. 3  The spindle assembly checkpoint 
12 
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MAPK Pathway 
 The mitogen activated protein kinase (MAPK) pathway is highly conserved from 
yeast to humans [92, 93].  MAPK signaling integrates a variety of extracellular and 
intracellular signals to control a broad spectrum of cellular processes including 
proliferation, survival, stress response and apoptosis [93].  A number of cooperating 
molecular mechanisms regulate the cascade in order to ensure signaling specificity.    
 
    
MAPK Cascade 
 The basic structure of the MAPK cascade is a module consisting of three kinases 
which sequentially activate one another through phosphorylation events.  The most 
upstream kinases in the cascade are the serine/threonine kinases, MAP kinase kinase 
kinases or MAPKKK (MAP3K).  Upon their own activation, MAP3Ks phosphorylate 
and activate the second kinase in the module, MAP kinase kinase or MAPKK (MAP2K) 
[93, 94].  MAP2Ks are defined as dual-specificity kinases, for upon their activation, they 
in turn phosphorylate a Thr-X-Tyr motif in the third cascade member, MAP kinase or 
MAPK [93, 95].  Substrates of MAPK include transcription factors, phospholipases and 
cytoskeleton-associated proteins.    
 The family of MAP3Ks, MAP2Ks and MAPKs is large, with at least 20 different 
members of the mammalian MAPK family identified to date [96].  The four most well 
described MAPK cascades are named for their relative MAPKs.  Jun amino-terminal 
kinases (JNKs) primarily serve in the response to cellular stress.  p38 is also activated in 
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response to cell stresses and plays a role in cytokine production in hematopoietic cells, 
cytokine-stimulated proliferation and apoptosis.  ERK5 is the least well known MAPK 
cascade [93] and it has been suggested that ERK5 regulates cell survival and proliferation 
[97, 98].  The most well studied MAPK pathway is extracellular signal-regulated kinases 
1 and 2 (ERK 1/2).   
 
Regulation and Functions of the ERK 1/2 Pathway  
 The ERK 1/2 cascade is implicated primarily in cellular proliferation, 
differentiation, cell cycle regulation and cell survival [93].  ERK 1/2 phosphorylates 
many known targets including transcription factors Elk1 [99], c-Fos [100] and p53 [101], 
all of which play a role in cellular proliferation and transformation.  As well, ERK targets 
include the S6 kinase p90/RSK [102], phospholipase A2 [103], EGFR [93] and several 
microtubule-associated proteins [103].    
 Activation of the ERK 1/2 cascade in response to mitogen stimulation has been 
well studied.  During cell cycle entry activation of the ERK1/2 cascade is triggered by 
engagement and oligomerization of extracellular growth factor receptors [104] which in 
turn, stimulates the conversion of Ras, a small GTP-ase, from its GDP-bound inactive 
form to an active GTP-bound form [96, 105].  GTP-bound Ras mediates the translocation 
of the MAP3K, Raf-1, to the membrane where it is activated by a yet undefined, 
phosphorylation mechanism [106].  Raf-1 activates MEK which transmits the signal to 
ERK1/2.  Activated ERK1/2 phosphorylates cytoplasmic targets or translocates into the 
nucleus where it phosphorylates transcription factors which promote S-phase progression 
[96, 105].   
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Mitotic Roles of ERK 1/2 
 It is well established that ERK 1/2 regulates the G1/S transition in response to 
mitogen stimulation [96, 105].  A large but lesser known body of evidence suggests that 
the ERK 1/2 pathway regulates various mitotic functions including entry and exit from 
mitosis, spindle assembly, the spindle assembly checkpoint and Golgi apparatus 
fragmentation (Fig. 4).  Despite a growing body of evidence supporting mitotic roles for 
ERK 1/2, a firm role for ERK 1/2 in mammalian mitosis has not been established. 
 Early evidence supporting a mitotic role for ERK 1/2 came from studies in 
Xenopus egg extracts where it was shown that p42 (the Xenopus ERK 2 homologue) is 
activated during M-phase [107-110].  As well, ERK activity during mitosis in NIH 3T3 
and HeLa cells is detectable via western blot analysis using antibodies that recognize 
activated ERK [111].   
 Importantly, reports using immunofluorescence microscopy support the early 
conclusions from Xenopus egg extracts that ERK is activated during mitosis.  Several 
groups have demonstrated that in mammalian cells small pools of active ERK 1/2 and 
MEK 1/2 are localized to the kinetochores and spindle poles throughout mitosis and to 
midbody during cytokinesis [112-114] (Fig. 4).  Activated p42 has also been shown to 
localize to mitotic spindles in Xenopus egg extracts [115] as well as in fertilized sea 
urchin eggs [116].   
 
                    
                    
Fig. 4  MAPK functions and localization during mitosis 
© 2006 Sergiy I. Borysov 
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 Functional studies have revealed roles for ERK 1/2 in mitotic entry in mammalian 
cells but not in Xenopus egg extracts.  In mammalian cells, expression of dominant-
negative MEK [117], treatment with MEK inhibitors [111, 117] and RNA interference 
(RNAi) of MEK 1/2 and ERK 1/2 [118] all induce a G2/M cell cycle arrest.  As well, 
such conditions decrease nuclear translocation of cyclin B-Cdk1 and delay and reduce its 
activation [111, 117, 118].  Such data supports a role for ERK 1/2 in Cdk1 activation and 
entry into mitosis in mammalian cells.  However, cyclin B-Cdk1 is not affected by the 
depletion of p42 from Xenopus egg extracts [110, 119].  To the contrary, constitutive 
activation of p42 in this system inhibits cyclin B-Cdk1 and delays entry into mitosis [120, 
121].  Further, evidence in Xenopus egg extracts revealed that p42 activates Wee1 kinase 
which directly phosphorylates and inactivates cyclin B-Cdk1 [122].  However, 
differences in the requirement of MAPK activity in mitotic entry between mammalian 
cells and Xenopus egg extracts, may be explained by their inherently different cell cycles.  
Indeed, while the cell cycle of somatic cells follows a classic G1-S-G2-M cycle, Xenopus 
egg extracts recapitulate the embryonic cell cycle, which is comprised only of S and M 
phases, with no gap phases in between.  Therefore, Xenopus egg extracts may not possess 
an active G2 phase molecular mechanism. Thus, a role for ERK 1/2 during mitotic entry 
remains disputable. 
 ERK 1/2 has been implicated in assembly of the mitotic spindle in several model 
systems.  Early work in mammalian cell culture showed that ERK 1/2 associates with 
[123] and phosphorylates components of the cytoskeleton [124-126], and it has been 
demonstrated that ERK 1/2 negatively regulates tubulin polymerization in Xenopus egg 
extracts [108, 115].  Immunodepletion of p42 or pharmacological inhibition of its 
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activation causes abnormal mitotic spindles to form in Xenopus egg extracts [115].  As 
well, inhibition of ERK 1/2 disrupts formation of the mitotic spindle in mammalian cells 
[115] and in sea urchin eggs [116].   
 It has been suggested that ERK 1/2 regulates spindle assembly through regulation 
of a mitotic motor protein CENP-E.  CENP-E is necessary for the establishment of 
chromosome-microtubule attachment and, therefore, is critical for proper spindle 
formation.  It has been demonstrated in mammalian cells that CENP-E is a mitotic 
substrate of ERK2, which phosphorylates CENP-E on sites that mediate its association 
with kinetochores [114].   
 In cycling Xenopus egg extracts, blockade of mitotic p42 activation shortens the 
duration of mitosis [119].  Along with kinetochore localization of ERK 1/2 in mammalian 
cells, this data suggests a potential role for ERK in regulation of the SAC.  Indeed, 
maintenance of an induced spindle assembly checkpoint arrest is compromised in p42 
depleted [109] or p42 inhibited [127] Xenopus egg extracts.   As well, loss-of-function 
mutations in Drosophila’s rolled/MAPK gene caused the abrogation of a colchicine 
induced mitotic arrest in Drosophila larvae [128].   
 Several reports have implicated MAPK in the regulation of SAC.  As mentioned 
above, the SAC arrest depends on several checkpoint proteins including BubR1, Bub3 
and Mad2 binding to Cdc20 to inhibit activation of the anaphase promoting complex 
(APC/C).  Using Xenopus egg extracts it was shown that during mitotic arrest MAPK 
phosphorylates Cdc20 on sites that increase its affinity for BubR1, Bub3 and Mad2 and 
negatively regulate the APC/C [129].  Another report demonstrated that MAPK 
phosphorylates Mps1, a critical SAC kinase, and this phosphorylation is necessary for 
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kinetochore localization of SAC proteins in Xenopus egg extracts [73].  Therefore, it has 
been proposed that ERK 1/2 is involved in regulating the SAC. 
 Supportive of an ERK 1/2  mitotic role in mammalian cells are studies 
demonstrating that constitutive activation of MAPK via expression of v-mos or v-ras 
expression in mouse fibroblasts causes cells to fail cytokinesis and become binucleated 
[130, 131].  This indicates that ERK inactivation is necessary prior to cytokinesis.  
However, further studies will be necessary in order to definitively establish that ERK 1/2 
regulate this critical mitotic stage.  
 Fragmentation of the Golgi apparatus during mitosis is an essential process and it 
is thought to be a method for partitioning Golgi membranes equally in both daughter cells 
[132].  It has been shown that mitotically activated MEK1 (the upstream activator of 
ERK1) localizes to Golgi membranes in late prophase [133, 134] and that Raf-1 
activation of MEK1 is required for mitotic Golgi fragmentation [133, 135, 136].  Further 
studies demonstrated that Golgi fragmentation is mediated through an unusual, truncated 
ERK isoform, ERK1c [137, 138].  ERK1c is regulated in an M-phase specific manner, 
becoming phosphorylated and localizing to the Golgi during early mitosis [138].  These 
findings indicate that activation of ERK 1/2 pathway during mitosis may differ from its 
S-phase activation. 
 In summary, ERK1/2 and their activators, MEK 1/2, localize to key mitotic 
structures in Xenopus egg extracts and in cells grown in culture. Functional studies reveal 
that ERK 1/2 plays roles in a variety of mitotic functions.  While a role for ERK 1/2 in 
Golgi fragmentation has been established in mammalian cells, roles in spindle assembly 
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formation and the spindle assembly checkpoint have primarily been studied in the system 
of Xenopus egg extracts.  
 
B-Raf Kinase 
 Raf kinases are serine/threonine kinases whose activities regulate a variety of 
cellular processes including growth, proliferation, survival, differentiation and apoptosis 
[96, 139, 140].  The Raf family consists of A-Raf, B-Raf and C-Raf (Raf-1), which 
function as MAP3Ks.  Nearly all reported Raf functions result from activation of the 
MAPK cascade.  Rafs share significant sequence identity and are structurally similar.   In 
spite of some similarities, Rafs have some significant differences in their regulation, 
tissue distribution and developmental functions.  While C-Raf is the prototypic Raf 
kinase, B-Raf has emerged as the most potent activator of MAPK signaling.   
 
 
B-Raf Protein Structure 
 B-Raf, A-Raf and C-Raf share a basic three-domain architecture including 
conserved domains, CR1, CR2 and CR3 (Fig. 5).  CR1 and CR2 are embedded within the 
N-terminal regulatory portion of Rafs, and CR3 resides in the C-terminal kinase domain.  
CR1 contains a Ras binding domain (RBD) and a cysteine rich domain (CRD) [141, 142], 
both of which provide interacting sites for upstream regulators such as Ras and Rap1 
[143].  The CR2 domain contains a negatively regulatory phosphorylation site [144-146] 
and a 14-3-3 binding phospho-epitope [147].  The CR3 domain is the kinase domain, 
comprised of the N-region and the activation loop, both of which contain phospho-sites 
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that regulate Raf activity.  Unlike A-Raf and C-Raf, B-Raf contains a unique N-terminal 
domain, the significance of which is unknown.  While A-Raf and C-Raf genes are 
transcribed into one transcript, B-Raf is alternatively spliced, generating several different 
B-Raf isoforms [148, 149].  The 95 KD isoform is the largest and most commonly 
studied and the significance of the smaller isoforms is not understood. 
 
B-Raf Activation 
 Raf kinases are activated by similar and distant mechanisms.  It is believed that 
the N-terminal regulatory domain of Rafs bind to the C-terminal kinase domain, creating 
a closed conformation which renders the kinase domain inaccessible for activation [150].  
Phosphorylation events and protein-protein interactions disrupts the N-terminal-C-
terminal interactions, opening the Raf protein which prepares it for activation [142, 143, 
151-155].  However, there are unique aspects to B-Raf’s regulation which explains its 
potent MEK kinase activity.
         
Fig. 5 Raf family members 
22 
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 B-Raf requires a lower “dose” of regulatory phosphorylation than does C-Raf for 
its activation.  Following Ras-mediated stimulation, C-Raf requires two stages of 
phosphorylation events including Ras and SRC mediated phosphorylation of Ser-338 and 
Tyr-341 in the N-region [156-159] and Ras mediated phosphorylation of Thre-491 and 
Ser-494 in the activation loop [140].  B-Raf, however, does not require phosphorylation 
within the N-region due to the presence of a constitutive phosphorylation on Ser-335 and 
a phospho-mimicking aspartic acid at residue 448 [158].  Therefore, Ras mediated 
activation of B-Raf requires phosphorylation of Thr-599 and Ser-602 within the 
activation loop [160].  It has been proposed that the constitutive presence of negative 
charges in the N-region of B-Raf inhibits the interaction between the regulatory and 
catalytic domains, rendering an open conformation [161].  These differences account for 
a higher basal level activity in B-Raf than C-Raf.   
Rafs are further regulated on the level of protein-protein interactions including 
direct interactions with Ras, Rap1 [162-167], MEK [149, 162-167] and C-Raf [168].  
While C-Raf and B-Raf both interact with Rap1, Rap1 mediates activation of B-Raf 
while it inhibits C-Raf and downstream MAPK signaling [163, 167, 169].  As well, B-
Raf and C-Raf both directly associate with MEK, however, B-Raf has a higher binding 
affinity to MEK than does C-Raf or A-Raf [170], which may account for the fact that B-
Raf is a stronger activator of MEK than C-Raf or A-Raf [158, 160].  It has also been 
shown that B-Raf heterodimerizes with C-Raf, and is required for activation of C-Raf 
[171, 172].  While B-Raf/C-Raf heterodimers possess higher kinase activity than both 
respective monomers [168], B-Raf can be sufficiently activated by Ras alone [161]. 
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B-Raf Functions 
 Analysis of Raf family members in knock-out mice has revealed that A-Raf, B-
Raf and C-Raf all play essential roles in embryogenesis.  Disruption of B-Raf causes 
embryonic lethality resulting from apoptotic death of differentiated endothelial cells 
[173].  Disruption of C-Raf leads to aberrations in lung development and A-Raf knock-
out mice generate neurological and intestinal abnormalities [173, 174].  Knock-out 
studies also reveal that B-Raf and C-Raf alleles can partially compensate for one another 
and exhibit some functional redundancy [174].   
Early studies revealed via northern blotting that B-Raf expression was restricted 
to tissues of the brain, testes and fetal membranes [175, 176].  However, the use of 
improved protein detection techniques demonstrated that B-Raf is ubiquitously expressed 
at low levels in most tissues with perhaps highest expression in the brain.  Subcellular 
localization of B-Raf has exclusively been reported as cytoplasmic, however, a thorough 
analysis of B-Raf subcellular localization has yet to be published.   
 Analyses of B-Raf’s specific cellular functions have been studied either in 
comparison with C-Raf and A-Raf, or relative to its oncogenic functions.  It was shown 
that B-Raf and A-Raf, but not C-Raf exhibit sustained activation by neuronal growth 
factor (NGF) in PC12 cells [177], and epidermal growth factor (EGF) activated all three 
Raf isoforms.  cAMP leads to activation of B-Raf in a Rap1/B-Raf dependent manner in 
neurons, whereas C-Raf is inhibited by cAMP [165, 178, 179].  It is widely presumed 
that B-Raf functions during S-phase in non-neuronal cells, however B-Raf’s non-
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neuronal functions have not been well studied nor distinguished from the functions of C-
Raf.   
 
B-Raf as a Mitotic MEK Kinase 
 It has been shown that ERK is activated during mitosis and contributes to normal 
mitotic functions.  A recent report from our laboratory demonstrated that B-Raf is the 
MAP3K (MEK kinase) responsible for mitotic activation of the MAPK pathway in 
Xenopus egg extracts [180].  It was shown that B-Raf is activated in an M-phase specific 
manner and is required for the mitotic activation of the MEK/MAPK pathway.  As well, 
the authors demonstrated that cyclinB-Cdk1 directly phosphorylates B-Raf and 
contributes to its activation during mitosis [181], suggesting that B-Raf activation at 
mitosis is mediated through mechanisms distinct from those that regulate MAPK 
signaling in response to mitogens.  Further, it was shown that MAPK regulates B-Raf 
through negative feedback phosphorylation, which is presumed to ensure transient 
activity of B-Raf during mitosis in Xenopus egg extracts [180].   
  
 In summary, B-Raf is a member of the Raf family of kinases, but it stands out due 
to its unique structural and functional features.  Cumulative evidence from the recent 
decade demonstrates that B-Raf is a major activator of the ERK 1/2 cascade.  As well, 
novel functions have been ascribed to B-Raf.  In particular, studies in Xenopus egg 
extracts have shown that B-Raf regulates the mitotic activation of MAPK. 
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MAPK Pathway in Tumorigenesis 
 It has long been recognized that the MAPK cascade is a key regulator of cellular 
proliferation and survival.  Thus, its continuous signaling could lead to cellular 
transformation.  Indeed, the MAPK pathway is hyperactivated in approximately 30% of 
human tumors.  Four well studied mechanisms of ERK activation in human tumors 
include mutations in the epidermal growth factor receptor (EGFR), Ras, the mitogen-
activated protein kinase phosphatases (MKPs) and B-Raf.   
 
EGFR, Ras and MKPs in Human Cancers 
 The epidermal growth factor (EGF) and its receptor, EGFR [182, 183] signals 
through Ras activating the MAPK pathway [184].  It has become well recognized that 
EGFR is an oncogene [185-188] and is highly expressed in human cancers and correlated 
with poor prognosis [189].  EGFR is frequently overexpressed or mutationally activated 
[190] in breast, lung and head and neck cancers, glioblastomas, bladder, colorectal, 
ovarian and prostate cancers [191-195].  As well, transforming growth factor alpha 
(TGFα), an EGFR’s ligand, is upregulated in a wide variety of transformed cells [196-
198] thus causing persistent stimulation of EGFR. 
 Ras proteins are a family of small GTPases that are upstream activators of Rafs 
and therefore activators of the MAPK cascade [199].  In normal quiescent cells, Ras is in 
its GDP-bound inactive form.  Following stimulation by EGF or other factors, Ras is 
transformed into its GPT-bound active form which then binds to and stimulates the 
activation of Rafs.  Ras is converted to its oncogenic form by missense mutations that 
render the proteins to be constitutively GTP-bound and active [200].  Since oncogenic 
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Ras cannot be inactivated, it drives activation of the Raf-MEK-ERK cascade in a 
stimulus-independent manner.  Oncogenic Ras occurs in 30% of human tumors including 
90% of pancreatic cancers, 50% of colon and thyroid cancers, 30% of lung cancers and 
myeloid leukemias, and 15% of melanomas [200-202]. 
  Recently it has come to light that several mitogen-activated protein kinase 
phosphatases (MKPs), negative regulators of the MAPK signaling, are involved in 
tumorigenesis [203].  MKPs are mutated in tumors of the breast, lung, prostate, ovaries, 
pancreas, liver and gastrointestinal tract.  Overexpression of several MPKs is observed in 
tumors and correlates with poor outcome and progression [204-206], thus serving as a 
prognostic marker [207].  However, in several tumors, MKPs are down regulated or 
grossly underexpressed [208, 209].  Growth of tumors in nude mice from Ha-ras 
transformed cells was greatly delayed when MKP expression was induced, supporting a 
tumor suppressor role for MKPs [210].  While the mechanisms of MKP deregulation are 
not yet fully understood, it has been shown that hypermethylation leads to loss of MKP-3 
expression in pancreatic cancers [211]. 
 
B-Raf in Human Cancers 
 Members of the Raf family were first identified as viral oncogenes causing tumors 
in mice and chickens [212-215].  C-Raf activity is increased in response to hyperactivated 
EGFR or Ras, however, to date B-Raf is the only Raf kinase that is known to be mutated 
in human cancers. 
 Two decades of testing human tumors for Raf mutations was largely unsuccessful 
until a fruitful, high-throughput screen of nearly 1000 human tumor samples identified B-
 28 
Raf missense mutations in many human cancers [216].  Activating B-Raf point mutations 
were discovered in nearly 70% of melanomas, 40% of papillary thyroid carcinomas [217-
219]; 14% of ovarian cancers, 14% of liver cancers, 12% of colorectal tumors, 11% of 
gliomas, 9% of sarcomas a to a lesser extent in other lymphomas, leukemias, breast, lung 
and liver carcinomas, totaling 8% of all tumors sampled [216].   
While more than 30 missense mutations were identified, all in the kinase domain 
of B-Raf, 80% of the mutations were accounted for by a single Valine to Glutamic acid 
substitution at residue 600, B-RafV600E [216].  Melanomas by far accounted for the 
highest percentage of B-Raf mutations, in which over 90% of the mutations were 
represented with the V600E substitution.  Ras mutations account for 15% of melanomas, 
however, Ras and B-Raf mutations are mutually exclusive in the vast majority of tumors, 
suggesting that Ras and B-Raf transform melanocytes through similar mechanisms.  As 
well, it has been shown that 80% of benign nevi harbor a B-RafV600E mutation [220], 
thereby implicating B-Raf in the early stages of transformation.  Additional studies have 
shown that a paracentric inversion within chromosome 7 creates a fusion protein between 
a portion of the AKAP9 gene and the kinase domain of B-Raf rendering B-Raf 
constitutively active [221].  This rearrangement is found at a low frequency (1%) of 
sporadic thyroid papillary carcinomas, however its prevalence is 11% among thyroid 
papillary carcinomas that developed in children as a result of exposure to radiation from 
the Chernobyl explosion.  Finally, less commonly noted are B-Raf copy number 
amplifications which occur most often in thyroid follicular adenomas (25%) and thyroid 
follicular carcinomas (35%) [222].       
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B-Raf as an Oncogene    
The most common mutation in B-Raf, V600E, is flanked by a threonine at residue 
599 and Serine at residue 602, both of which require phosphorylation for Ras mediated 
activation [160].  It is therefore conjectured that the negative charge acquired by 
substituting glutamic acid for valine suffices as a phospho-mimic capable of activating B-
Raf [216].  Indeed, the vast majority of mutations in B-Raf were demonstrated to be 
activating mutations, with B-RafV600E exhibiting a 10.7 fold increase in its kinase activity 
in vitro over wild-type B-Raf.  The activating mutations increased endogenous ERK 
activation in cell culture, as tested by levels of ERK1/2 phosphorylation, whereas 
overexpression of wild-type B-Raf did not increase ERK1/2 phosphorylation [223].  
Interestingly, four rare B-Raf mutations found in tumors [216] have reduced in vitro 
kinase activity [224] despite activating ERK in cells.  It was shown that three of these 
exogenously expressed mutants, interact with and activate endogenous wild-type C-Raf, 
which then activates ERK [224].      
Consistent with its elevated kinase activity, it was shown that B-RafV600E is 
capable of inducing transformation in NIH3T3 cells [216] and immortalized mouse 
melanocytes [223] in an ERK dependent manner.  Further, transformation of melanoma 
cells expressing B-RafV600E was reversed upon downregulation of B-Raf [225, 226].  
Additionally, it was shown that immortalized melanocytes expressing B-RafV600E form 
tumors in nude mice.  Consistent with the presence of B-RafV600E mutations in 80% of 
benign nevi, transgenic zebrafish expressing B-RafV600E formed benign nevi [227].  
However, B-RafV600E induced formation of invasive melanomas in zebrafish, only when 
expressed on a p53 deficient background.  A conditional B-RafV600E knock-in mouse 
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model produces hematopoietic displasia and skin polyps [228].  Transgenic mouse 
models targeting B-RafV600E to melanocytes [229] or the lung [230] rapidly develop 
benign nevi or adenomas, respectively, but rarely develop melanomas or 
adenocarcinomas unless combined with the loss of tumor suppressors Pten, TP53 or 
Ink4a/Arf.  However, targeted expression of B-RafV600E to the thyroid serves as a tumor 
initiator and promoter, resulting in rapid accumulation of parathyroid carcinomas (PTC) 
that closely reflect human PTCs [231].  Therefore, B-RafV600E is capable of transforming 
immortalized cells and causing benign tumor formation in several animal models.  
However, its role in tumor progression varies amongst tumor types, requiring additional 
mutations for full transformation to occur. 
 
In summary, MAPK signaling has been implicated in a high percentage of human 
tumors.  Hyperactivity of the Ras-Raf-MEK-ERK pathway is achieved by mutations on 
various levels including the upstream activator EGFR, its ligand, TGFα, activating 
mutations in Ras and deregulation of MPKs.  Most notably, B-Raf is constitutively 
activated in a wide variety of cancers which depend on oncogenic B-Raf expression for 
proliferation and survival.  80% of benign nevi harbor oncogenic B-Raf, suggesting that 
it is an early transformation event.   
 
Mitosis and Cancer 
 It has long been recognized that human tumors are genetically unstable.  
Nucleotide-level genomic instability and gene mutations are well established causes of 
tumorigenesis.  However, the form of genetic instability most frequently observed in 
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cancers is mitotically driven chromosomal aneuploidy.  Mounting evidence supports a 
causal role for chromosomal aneuploidy in tumorigenesis, therefore, understanding how 
mitosis drives aneuploidy in human tumors has become a critical question of modern 
cancer biology.   
 
Types of Genomic Instability 
Human disease is largely attributed to genetic alterations [232].  Mutations in 
genes which repair or divide the genome cause cells to continuously acquire genomic 
changes over time rendering them genomically unstable.  The two categories of genomic 
instability include nucleotide-level instabilities and mitotically driven aneuploidy [232].   
 The human genome contains thousands of microsatellites, short sequences of 
DNA that are tandemly repeated 10 to 100 times [233].  Microsatellites are highly 
susceptible to DNA replication errors, which are repaired by the highly conserved DNA 
mismatch repair (MMR).  Mutations in MMR genes and occasionally mutations in the 
nucleotide excision repair (NER) genes [234] increase the rate of genomic mutations 
leading to microsatellite instability (MIN), the most common type of nucleotide-level 
genomic instability [232].  MIN occurs in approximately 13% of sporadic colorectal, 
endometrial and gastric cancers [235, 236].  It is widely accepted that MIN drives 
tumorigenesis [237].   
 Normal human cells contain 46 chromosomes.  Deviation in chromosome number 
is referred to as aneuploidy.  Gains and losses of whole chromosomes, gene 
amplifications and deletions and chromosomal rearrangements and are all forms of 
aneuploidy [232, 235, 237].  Embryogenic aneuploidy is typically lethal and when viable, 
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causes disease such as Down, Edward and Patau’s syndromes [238].  However, nearly 
every tumor cell exhibits aneuploidy and the vast majority of tumor cells are genetically 
unstable [239].     
 Continual chromosomal gains and losses, a form of genomic instability termed 
chromosomal instability (CIN), is the most common form of aneuploidy in tumors [232, 
237, 239].  Nearly all tumors that do not exhibit MIN are chromosomally unstable, often 
containing gross structural changes such as translocations, deletions and amplifications 
[237], as determined by classic and modern karyotype analyses.  Structural 
rearrangements in the absence of whole-chromosomal instability are a well accepted 
cause of tumorigenesis, such as the BCR-ABL translocation that drives some cases of 
chronic myelogenous leukemias [240].  The role of CIN in tumorigenesis is less well 
defined.  Some have argued that chromosomal aneuploidy is a side-effect of 
tumorigenesis.  However, correlative evidence and direct experimental results have 
demonstrated that chromosomal aneuploidy contributes to cellular transformation and 
cancer development. 
 
Mitosis and Aneuploidy 
For well over a century it has been demonstrated that aneuploidy results from 
errors in cell division [241].  Some of the mitotic defects which cause aneuploidy include 
multipolar spindle formation, defects in chromosome cohesion, spindle-microtubule 
misattachments, and a weakened spindle assembly checkpoint [242]. 
Cells that form multi-polar spindles undergo chromosomal missegregation.  It is 
believed that multi-polar spindles result from defects in the duplication, segregation and 
 33 
maturation of centrosomes.   Indeed, Aurora A amplification [243] or inactivation of p53 
[244], BRCA1 and BRCA2 [245-248] or mitotic motor protein Eg5 cause errors in 
centrosomal duplication or segregation leading to spindle malformation and aneuploid 
daughter cells.   
 Defects in the cohesion of chromosomes have been shown to cause aneuploidy.  
Inactivation of securin or separase homologues in budding and fission yeast generates 
hypoploidy [249-251].  As well, deletion of securin from human cancer cells induces 
high levels of CIN [252].    
  Another potential mechanism for aneuploidy lies within faulty kinetochore-
microtubule engagement.  Merotelic attachments occur upon inhibition of the 
chromosomal passenger complex that corrects kinetochore-microtubule attachment errors 
[253].  As well, truncated forms of the adenomatous polyposis coli protein generate CIN 
by disrupting kinetochore-microtubule attachments [254-256].  
 An insufficiently performing spindle assembly checkpoint is also implicated in 
the production of aneuploidy [257].  Mice with reduced levels of Mad2 [258], BubR1 
[259] or Bub3 [260] have a defective SAC and are prone to the acquisition of aneuploidy.  
While Mad2, BubR1 and Bub3 have roles throughout the cell cycle, CENP-E functions 
exclusively during mitosis [261].  Therefore, it is significant that reduction in CENP-E 
levels compromises the SAC and causes aneuploidy in vitro [262] and in mice [263].  
 
Causal Role for Aneuploidy in Tumorigenesis 
 Aneuploidy is the most common feature found amongst tumors and is considered 
a hallmark of cancer [237].  Some of the earliest cancer biologists proposed that 
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aneuploidy causes tumorigenesis [264-266].  It is now widely accepted that changes in 
gene expression lead to tumorigenesis [267].  Despite arguments that aneuploidy is a 
benign consequence of transformation [268], modern biology suggests that mutations in 
genes that regulate cell division drive aneuploidy, which is ultimately the means for 
generating changes in gene expression that lead to tumorigenesis [232, 235, 269, 270].    
Tumor development results from accumulated changes in gene expression.  Some 
have argued that the accumulation of a few somatic mutations is sufficient to cause 
transformation [271].  However, mathematical modeling predicts that the acquisition of 
sufficient numbers of changes cannot be achieved solely by the acquisition of 
spontaneous mutations [272].  Mathematical models also predict that the onset of 
genomic instability is an early and necessary event in tumor development [235].  In fact, 
allelic loss occurs in extremely small polyps in early stage colorectal cancers [273], and 
aneuploidy is present in precancerous lesions of the cervix, head and neck, esophagus and 
bone marrow [274].  Human tumors gain and lose chromosomes at a rate of 10-100 times 
higher than normal cells [239].  Average tumors of the colon, prostate and breast have 
lost 25% of their alleles [232] and exhibit heterogeneity due to continual genomic 
changes [275]. 
 It has been demonstrated that a large number of CIN colorectal tumors cannot 
adequately activate their spindle assembly checkpoint [276].  In fact, a large proportion 
of human tumors display misexpression of genes that regulate the SAC.  BubR1 and 
Mad1 are frequently misregulated in a number of human cancers [261].   Mad2 was 
found to be transcriptionally overexpressed in several tumor types including 
hepatocellular, lung and intestinal carcinomas, B cell lymphomas and several others 
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[277].  Mutational inactivation of Bub1 or BubR1 have been observed in colon cancers 
[276]. Several tumor types, including pituitary adenomas and mammary and pulmonary 
adenocarcinomas, exhibit overexpression of securin [278-280].  Other genes that regulate 
mitosis such as Apc, BRCA1 and BRCA2 are misregulated in a number colorectal, 
duodenal, breast, ovarian, colon and pancreatic cancers [261].   
Direct evidence has demonstrated that aneuploidy can drive tumorigenesis.  In 
2007, it was reported that cells from Mad2 transgenic mice become highly aneuploid and 
develop a wide variety of tumors including liver and lung carcinomas, sarcomas and 
lymphomas [277].  The mice developed whole chromosomal aneuploidy and structural 
chromosomal abnormalities, as shown by g-banding analysis.  Immunofluorescence 
studies demonstrated that Mad2 cells exhibit lagging chromosomes and chromosome 
bridges during mitosis – a strong indication that mitotic errors were the driving factor 
behind the acquisition of aneuploidy.   As well, it was shown that transient Mad2 
expression is sufficient for long-term tumor development, suggesting that aneuploidy 
induced by Mad2, rather than Mad2 itself, was necessary for tumor maintenance.  
Further direct evidence that aneuploidy is tumorigenic comes from studies in mice 
with reduced CENP-E levels [263].  These studies are particularly significant since the 
role of CENP-E is exclusively relegated to mitosis.  Mice heterozygous for CENP-E 
exhibit whole chromosomal aneuploidy, in the absence of structural abnormalities, as 
shown by spectral karyotyping.  Lagging and pole-associated chromosomes were 
detectable in 40% of cells isolated from CENP-E heterozygous mice, implicating mitotic 
errors as the cause of aneuploidy.   After a long latency period, these mice develop 
splenic lymphomas and lung adenomas at a rate of 10%, comparable to the number of 
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smokers who develop lung cancer.  The long latency period indicates that a small subset 
of the aneuploid cells have the potential to drive transformation.  In the presence of other 
aneuploidy-inducing carcinogens, CENP-E heterozygous mice had a reduced incidence 
of tumorigenesis, indicating that a significantly high level of aneuploidy is incompatible 
with life [261]. 
  
In summary, mitosis must be accurately executed in order to preserve the genomic 
integrity of a cell.  Mitotic proteins, whose misregulation drives aneuploidy in vitro, are 
frequently misexpressed in human tumors.  Nearly all tumors are aneuploid and 
genomically unstable from an early stage in tumor development and the degree of 
aneuploidy is directly correlated with the stage of tumorigenesis.  As well, direct studies 
of Mad2 and CENP-E confirm that mitotically induced aneuploidy is tumorigenic in 
mice.  Together, these observations support the assertion that misexpression of spindle 
assembly proteins promote aneuploidy, which can contribute to tumorigenesis.   
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Hypothesis and Dissertation Statement 
 
Recently, it has come to light that B-Raf is a prominent oncogene, mutated in a 
wide spectrum of tumors including nearly 70% of melanomas.  Oncogenic B-Raf is also 
expressed in 80% of benign nevi, indicating that it plays an early role in tumorigenesis.  It 
is crucial to understand the molecular mechanism by which oncogenic B-Raf contributes 
to tumorigenesis.  The cellular mechanisms through which oncogenic B-Raf may drive 
transformation are beginning to be appreciated.  However, more work is needed in order 
to understand the full effects of oncogenic B-Raf.    
It is well accepted that B-Raf is the most potent activator of MAPK signaling 
[158, 160].  The MAPK pathway is a critical signal transduction pathway necessary for 
cellular proliferation, cell survival, stress response and apoptosis [93].  MAPK signaling 
is also involved in the regulation of mitosis [108-110, 113, 114, 119, 134].  Interestingly, 
B-Raf has been reported to activate MAPK signaling during mitosis in Xenopus egg 
extracts [180], however, little is known about B-Raf functions in human cells.  I 
hypothesize that B-Raf regulates mitotic functions in human somatic cells and that 
oncogenic B-Raf disrupts mitosis, leading to aneuploidy.  
To address these hypotheses, I conducted loss-of-function experiments in cell 
cultures in order to evaluate the contribution of B-Raf to mitosis.  Further, I introduced 
oncogenic B-Raf into cancer, immortalized, and primary cells, evaluating the cells 
mitoses and analyzing their karyotypes.   
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The results of my thesis work demonstrate that B-Raf regulates several critical 
mitotic functions and that oncogenic B-Raf perturbs mitosis, driving aneuploidy and 
chromosomal instability. 
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CHAPTER 2 
SUBCELLULAR B-RAF LOCALIZATION 
 
Introduction 
 Regulatory functions of MAPK signaling are mediated in large part by the 
subcellular localization of MAPK pathway members.  Active forms of MEK and ERK 
localize to the cytoplasmic compartment in order to phosphorylate substrates localized at 
the cytoskeleton structures and they translocate into the nucleus to regulate gene 
expression by phosphorylating transcriptional factors [281, 282].  During mitosis, active 
MEK and ERK colocalize to the mitotic spindle poles, the kinetochores, the midzone of 
the anaphase spindle and the telophase bridge during cytokinesis [112].  Little has been 
published on the subcellular localization of B-Raf with the exception of its localization 
throughout the cell body of post-mitotic neural cells [283].   
 B-Raf is itself regulated by phosphorylation events.  Ras mediated activation of 
B-Raf requires phosphorylation on two key residues (Ser 599 and Thr 602) in B-Raf’s 
kinase domain.  Evaluating the localization of dually phosphorylated B-Raf can give 
clues to the cellular positioning of active B-Raf. 
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Results 
B-Raf Localizes to Mitotic Structures 
 MEK and ERK, members of the MAPK signaling cascade, localize to mitotic 
structures when activated by phosphorylation.  Work from our laboratory has revealed 
that B-Raf is critical for mitotic activation of the MAPK cascade and its activity is 
regulated in an M phase-dependent manner [180].  Therefore it stands to reason that B-
Raf might also exhibit mitosis-specific localization. 
 
B-Raf is Detected at the Mitotic Spindle 
In order to test whether B-Raf localizes to the mitotic spindle apparatus, 
immunofluorescence studies were carried out in cycling NIH 3T3 cells (Fig. 6), MCF-7 
cancer cells (data not shown) and human foreskin fibroblast (HFF) cells (Fig. 7) using a 
monoclonal alpha-tubulin antibody to stain the mitotic spindle, DAPI to visualize the 
chromosomes and a commercially available, polyclonal antibody against B-Raf.  This 
antibody recognizes a single, 95 kD protein band in corresponding cellular lysates (data 
not shown).  B-Raf was exclusively detected in the cytoplasmic compartment of 
interphase cells.  Interestingly, as shown in HFF cells, at the onset of mitosis or prophase 
(as determined by chromosome condensation and aster formation), B-Raf localizes to the 
nuclear region.  As cells enter metaphase, B-Raf becomes highly enriched in the region of 
the mitotic spindle and the spindle poles and to the spindle and midzone during anaphase.  
This was most evident upon utilizing a threshold analysis, which distinguishes the areas 
containing the highest relative levels of B-Raf staining.  In late telophase and cytokinesis, 
the B-Raf staining pattern was mostly confined to the cytoplasmic compartment, as it was  
  
 
 
 
 
 
 
 
    
Figure 6.  B-Raf localizes to the mitotic spindle in NIH 3T3 cells 
a.  Immunofluorescence staining of endogenous B-Raf protein.  a. B-Raf; b  
threshold analysis depicting regions of strong B-Raf enrichment; c. overlay 
α-tubulin to visualize the spindle (red) and DNA (blue); Images were 
acquired at 100X magnification, scale bar represents 3µm, arrows depict 
mitotic cells.   
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Fig. 7  B-Raf localizes to the mitotic spindle in HFF cells  
Top Panel:  Immunofluorescence in asynchronous HFF cells of endogenous B-
Raf protein (green) Bottom Panel:  Overlay of B-Raf threshold (green), α-
tubulin (red) and DNA stained with DAPI (blue).  Images were acquired at 
100X magnification. 
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during interphase.  The enrichment of B-Raf staining at the metaphase spindle region was 
also observed using a mouse monoclonal B-Raf antibody, indicating that the staining 
pattern from the two antibodies reflects the detection of B-Raf protein.  Neither the 
isotype control for the polyclonal (Rabbit IgG) nor monoclonal (Mouse IgG2b) generated 
any appreciable staining pattern.   
To further ascertain whether B-Raf’s mitotic staining co-localizes to microtubule 
spindle structures, I used confocal microscopy to acquire 0.45 μm z-sections throughout 
HFF cells.  The results demonstrate that B-Raf staining was restricted to the confocal 
sections containing spindle microtubules and condensed chromosomes (Fig.8).  Strong B-
Raf staining appears at the spindle poles and the spindle midzone in cells undergoing 
metaphase and anaphase, respectively.  Viewing metaphase cells down the spindle pole 
axis permits us to visualize B-Raf along the radial microtubules and at the spindle poles.  
Thus, B-Raf localization is enriched at the spindle apparatus during mitosis in somatic 
tissue culture cells. 
 
B-Raf Interacts with Spindle Microtubules 
Immunofluorescence staining demonstrates that B-Raf is enriched at the region of 
the mitotic spindle, and therefore B-Raf may be directly associated with the microtubules 
of the spindle apparatus.  In order to address this question, entire z-series of 
immunofluorescence images of B-Raf and the mitotic spindle were analyzed with Imaris 
Bitplane 3D blind deconvolution followed by processing with the ImarisColoc module to 
isolate, visualize and quantify region overlap.  These analyses demonstrated that a portion
  
                                
 
                                            
B-Raf Spindle  DNA Overlay 
Metaphase 
Metaphase 
y-axis 
Anaphase 
Figure 8.  B-Raf is detected at the spindle apparatus during mitosis in HFF 
cells   
Confocal microscopy of HFF cells stained with antibodies against endogenous 
B-Raf (red), α-tubulin to visualize the spindle (green) and DNA stained with 
DAPI (blue).  Images represent 0.48µm along the z-axis from within a z-series.   
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of B-Raf directly colocalizes with the polymerized microtubules of the spindle (Fig. 9), 
suggesting that B-Raf directly interacts with the spindle microtubules.   
In order to validate the Imaris data, HFF and HeLa cells were exposed to 
nocodazole in order to depolymerize the microtubules.  Cells were stained with tubulin 
and B-Raf antibodies and the B-Raf staining pattern was assessed by fluorescence 
microscopy.  As shown in Figure 10, the staining pattern of B-Raf corresponding to the 
metaphase spindle was radically altered upon nocodazole treatment indicating that B-Raf 
localization at metaphase reflects its association with the spindle microtubules.   
 Based on the same principals of nocodazole function, we performed a 
biochemical experiment in Xenopus egg extracts to determine if B-Raf interacts with 
polymerized microtubules during mitosis and if the interaction is disrupted when 
microtubules are depolymerized by nocodazole.  As shown in Figure 11, B-Raf and 
polymerized microtubules are associated in a pelleted fraction of egg extracts and the 
association is decreased when microtubules are depolymerized with nocodazole.   
 
B-Raf Localizes to the Centrosomes 
 Based on the immunofluorescence threshold analyses and confocal data 
demonstrating an abundance of B-Raf at the spindle poles during mitosis, I decided to 
analyze mitotic cells for B-Raf colocalization to the centrosome.  The centrosome is 
comprised of an abundance of proteins concentrated into two centrioles.  The centrosome 
and its associated proteins can be detected following a brief detergent extraction of 
soluble proteins.  NIH 3T3 or HFF cells were briefly extracted with CHAPS
  
                     
 
 
 
 
 
 
 
                            
Fig. 9  B-Raf interacts with the spindle microtubules 
in HFF cells  
Confocal images of B-Raf and the spindle were 
analyzed using Imaris Bitplane 3D blind deconvolution.  
Following deconvolution, resulting stack was processed 
with ImarisColoc module to isolate, visualize and 
quantify region overlap.  Green represents α-tubulin, red 
is background B-Raf staining and yellow represents 
areas where B-Raf and microtubules interact. 
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Fig. 10  B-Raf spindle localization is disrupted when microtubules are 
depolymerized with nocodazole  
HFF and HeLa cells were treated for two hours with nocodazole to induce 
destabilization of microtubules.  Cells were fixed with 4% paraformaldehyde 
and processed for immunostaining of B-Raf (green) and α-tubulin (red), and 
DAPI was used to detect DNA (blue).  D=DMSO; N=Nocodazole.   
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Fig. 11  B-Raf co-pellets with microtubules isolated 
from M phase Xenopus egg extracts  
Spindle microtubules structures formed in mitotic 
Xenopus egg extracts, in the absence or presence of 10 
ng/μl nocodazole, were pelleted through a 40% 
glycerol buffered cushion as previously described 
(Horne Guadagno, 2003). The microtubule pellet and 
its associated proteins were resuspended in SDS 
sample buffer, separated by 10% SDS-PAGE, and 
subjected to immunoblot analysis for α-tubulin and B-
Raf. 
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detergent, fixed with 4% paraformaldehyde, stained for B-Raf, tubulin and DAPI to 
visualize the chromosomes.  The results showed that throughout the cell cycle the 
majority of B-Raf was removed by CHAPS extraction with the exception of two discrete 
pairs of foci on opposite sides of the aligned chromosomes, a distinct centriolar staining 
pattern (Fig. 12).  To confirm that B-Raf colocalizes directly with the centrioles, cells 
were costained with B-Raf and centrin, a centriole marker, followed by confocal analysis 
of 0.45 μm Z-sections.  Both pairs of foci co-localized precisely with centrin in both 
NIH3T3 (Fig. 12) and HFF (Fig. 13) cells during mitosis.  As shown in Fig. 14, B-Raf is 
present at the centrosome throughout the cell cycle.  Hence, we conclude that a detergent-
resistant pool of B-Raf is tightly associated with the centrioles in mammalian cells. 
 
B-Raf is Phosphorylated on Serine 599 and Threonine 602 at Mitotic Structures 
 B-Raf is dually phosphorylated at conserved residues Thr599 and Ser602 during 
Ras-mediated activation (Zhang and Guan, 2000), therefore dual phosphorylation of B-
Raf suggests that B-Raf is active and capable of phosphorylating downstream targets.  To 
determine whether B-Raf is phosphorylated at these two residues during mitosis, HFF 
cells were subjected to immunostaining with a monoclonal alpha-tubulin antibody, a 
phospho-B-Raf (Thr599/Ser602) antibody and DAPI to visualize the DNA.   
 
Phosphorylated B-Raf Localizes to the Centrosomes  
 During interphase, phospho-B-Raf (Thr599/Ser602) staining was weakly visible 
at the centrosome and the remainder of the cells is devoid of phospho-B-Raf staining, 
however, a notable staining pattern of phospho-B-Raf (Thr599/Ser602) was detectable 
  
 
 
       
 
 
           
 
 Figure 12  B-Raf localizes to the centrosomes in NIH 3T3 cells 
Immunofluorescence of endogenous B-Raf protein.  Cells were incubated with 1% CHAPS containing buffer, prior to 
fixation, in order to wash away soluble proteins and retain insoluble proteins and proteins tightly associated with 
insoluble structures.  Cells were stained with antibodies against endogenous B-Raf (green), centrin to visualize the 
centrosome (red) and DNA (blue).  Images were acquired at 100X magnification, scale bar represents 3µm.  Centrioles 
are magnified 4X in the outset panel. 
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Figure 13  B-Raf localizes to the centrosomes in HFF cells 
Immunofluorescence of endogenous B-Raf protein.  Cells were incubated with 1% CHAPS containing 
buffer, prior to fixation, in order to wash away soluble proteins and retain insoluble proteins and proteins 
tightly associated with insoluble structures.  Cells were stained with antibodies against endogenous B-Raf 
(green), centrin to visualize the centrosome (red) and DNA (blue).  Images were acquired at 100X 
magnification.  Centrioles are magnified 5X in the outset panel. 
 
  
 
 
     
     
 
                   
 
 Figure 14  B-Raf localizes to the centrosomes throughout the cell cycle 
Immunofluorescence of endogenous B-Raf protein.  Cells were incubated with 1% CHAPS 
containing buffer, prior to fixation, in order to wash away soluble proteins and retain 
insoluble proteins and proteins tightly associated with insoluble structures.  Cells were stained 
with antibodies against endogenous B-Raf (green), α-tubulin to visualize the spindle (red) and 
DNA (blue).  Images were acquired at 100X magnification.   
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during all stages of mitosis (Fig. 15).  At prophase, the onset of mitosis, strong phospho-
B-Raf staining was detectable at the centrosomes and remained at the spindle poles 
throughout metaphase and anaphase.  This staining pattern was nearly identical to the 
non-phosphorylated B-Raf centrosomal staining.  Additionally, phospho-B-Raf 
(Thr599/Ser602) staining was detected at the spindle midzone in cells undergoing 
anaphase and, at the midbody in late telophase cells undergoing cytokinesis.  
Collectively, these results indicate that pools of active B-Raf localize to specific spindle 
structures including the centrosomes during cell division. 
 
Phosphorylated B-Raf Localizes to Condensed Chromatin 
While phospho-B-Raf (Thr599/Ser602) staining was exclusively detected at the 
centrosome during interphase, staining became prominent at the nuclear region 
containing condensed chromosomes during prophase, in agreement with the staining 
pattern for total B-Raf protein (Fig. 7).  During metaphase, phospho-B-Raf 
(Thr599/Ser602) staining was concentrated at regions surrounding the aligned 
chromosomes (Fig. 15).  The perichromosomal space is the region that directly encircles 
each condensed chromosome.  Many proteins localize to the perichromosomal space 
during mitosis and the functions of these proteins and the perichromosomal region have 
not been fully defined.  However, it has been shown that several components that localize 
to the perichromosomal space are involved in mitotic functions such as chromosome 
condensation, decondensation, mitotic progression, cytokinesis and nuclear envelope 
reformation following exit from mitosis.  In order to directly address whether B-Raf is 
phosphorylated in a perichromosomal fashion, chromosomes were isolated from 
          
 
 
                                         
 
Figure 15  B-Raf is phosphorylated at key mitotic structures 
HFF cells were immunostained for phospho-B-Raf using a phospho-B-Raf 
(Thr599/Ser602) antibody (b.).  Microtubules and DNA (a.) were detected with 
anti-α-tubulin antibody and DAPI.  Images were captured at 100X magnification.  
Overlay is shown in c and d - d is magnified 4X.  Scale bar represents 10 μm.  
Arrows point to the centrosomes and the midbody. 
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 Figure 16  Phosphorylated B-Raf localizes to the condensed chromosomes 
Phospho-B-Raf (Thr599/Ser602) localizes to the perichromosomal space during metaphase, but 
not interphase.  Chromosomes were isolated from HeLa cells treated with nocodazole for 2 hrs 
and subjected to immunostaining and visualized with confocal microscopy.  Kinetochores were 
visualized with CREST antiserum (red); green foci represent phospho-B-Raf staining.  Shown 
are single 0.45 μM sections from within a z-series of a metaphase cell.  A metaphase cell is 
shown in the center of each panel surrounded by three interphase cells, in which no 
colocalization is observed. 
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Figure 17  Phosphorylated B-Raf localizes to the perichromosomal sheath 
Phospho-B-Raf (Thr599/Ser602) localizes to the perichromosomal sheath 
during metaphase, but not interphase.  Images from figure 18 were analyzed 
using Imaris doconvolution software and a 3D isosurface model was rendered.  
Kinetochores were visualized with CREST antiserum (red); green foci 
represent phospho-B-Raf and chromosomes are shown in blue (DAPI).  A 
metaphase cell is shown in the center and an interphase cells, in which no 
colocalization is observed, to the bottom left of the panel.  Joseph Johnson 
created this image. 
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interphase and metaphase cells, spun onto coverslips and stained with DAPI and the 
phospho-B-Raf antibody.  Confocal microscopy revealed that phospho-B-Raf 
(Thr599/Ser602) encircles each individual chromosome during metaphase, whereas no 
chromatin associated staining was detected in interphase cells (Fig. 16).  The 
perichromosomal staining is further supported by rendering a three-dimensional 
isosurfacing model of the chromosomes (Fig. 17). 
 
Phosphorylated B-Raf localizes to the Kinetochores 
Confocal imaging of B-Raf staining in HFF cells revealed discrete foci detectable 
along the metaphase plate of aligned chromosomes (Fig. 8, metaphase) reminiscent of 
kinetochores.  A view along the spindle pole axis (Fig. 8, metaphase y-axis) showed these 
foci appeared as a ring-like structure that co-localized at the juncture where spindle 
microtubules meet the aligned chromosomes, typically the site of the kinetochores.  Close 
inspection phospho-B-Raf (Thr599/Ser602) staining revealed the appearance of foci 
overlapping with chromosomes during metaphase and anaphase (Fig. 15, row d).  To 
determine whether these foci were localized at kinetochores, metaphase chromosomes 
were isolated from nocodazole-treated HFF cells, fixed and adhered to coverslips.  
Chromosomes were subjected to immunofluorescence analysis.  Co-staining with the 
kinetochore marker CREST antiserum and phospho-B-Raf showed that phospho-B-Raf 
foci overlap directly with every pair of kinetochores of metaphase chromosomes (Fig. 18, 
metaphase).  In contrast, interphase nuclei demonstrated no kinetochore colocalization of 
phospho-B-Raf (Fig. 18, interphase).  These results demonstrate that phospho-B-Raf 
(Thr599/Ser602) co-localizes with the kinetochores during metaphase.  
          
 
 
                                         
 
 
                                  
 
 
      Figure 18  Phosphorylated B-Raf localizes to the kinetochores during mitosis 
Phospho-B-Raf (Thr599/Ser602) stained foci co-localize to kinetochores at metaphase, but not 
interphase, chromosomes.  Chromosomes were isolated from HeLa cells treated with 
nocodazole for 2 hrs and subjected to immunostaining and visualized with confocal 
microscopy.  Kinetochores were visualized with CREST antiserum (red); green foci represent 
phospho-B-Raf staining.  Shown are single 0.45 μM sections from within a z-series of a 
metaphase cell.  
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Conclusions 
 Prior to my studies, reports on the subcellular localization of B-Raf were limited 
strictly to the cytoplasm of interphase neurons.  My results demonstrate that B-Raf 
localization and phosphorylation is cell-cycle specific.  Specifically, B-Raf localizes to 
and is phosphorylated at mitotic structures, many of which are known to play a critical 
role in the accuracy and timing of mitosis.    
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CHAPTER 3 
B-RAF PERFORMS CRITICAL MITOTIC FUNCTIONS 
 
Introduction 
 Previous studies from our laboratory show a role for MAPK in promoting the 
formation and stability of the mitotic spindle [115].  Specifically, blocking MEK activity 
or depleting p42 MAPK from Xenopus egg extracts inhibits spindle assembly and leads 
to the generation of aberrant half spindles, a portion with unfocused poles, and 
microtubule (MT) asters.  Moreover, when mammalian cells are treated during late G2 
and M phases with the pharmacological MEK inhibitor U1026, a high frequency of 
spindle abnormalities and misaligned chromosomes is observed indicating that MEK 
signaling is also important for spindle functions in somatic cells.  A role for B-Raf in 
activating the MAPK cascade during mitosis has been suggested from studies in Xenopus 
egg extracts that mimic the early embryonic cell cycles of S and M phases [180].  As 
well, it has been reported that peaks of B-Raf activity are detected at M phase and early 
G1 phase during the cell cycle of HeLa cells [134], but hard evidence for B-Raf having a 
role in regulating mitosis in somatic cells had not been described.  The studies described 
in this chapter show evidence for mitotic functions of B-Raf at mitosis in human somatic 
cells.   
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Results 
B-Raf Contributes to Mitotic Spindle Assembly in Xenopus Egg Extracts 
 Work from our laboratory has shown that proper mitotic spindle assembly in 
Xenopus egg extracts requires ERK phosphorylation.  In the same system, we have 
shown that B-Raf is the MEK kinase which activates ERK signaling during mitosis.  B-
Raf and ERK activities do not regulate S-phase functions in Xenopus egg extracts, as they 
are strictly relegated to mitosis.  These data suggests that B-Raf may regulate spindle 
assembly in Xenopus egg extracts through direct effects on mitosis.   
 
Spindle Assembly is Compromised in the Absence of B-Raf in Xenopus Egg Extracts 
 Xenopus egg extracts are a powerful biochemical system for studying the 
regulation of spindle assembly.  Antibodies can be used to efficiently immunodeplete 
endogenous proteins and spindle assembly can be monitored.  As shown in figure 19, B-
Raf protein in Xenopus CSF-arrested egg extracts is immunodepleted using B-Raf 
antibodies but not rabbit IgG mock control.  Metaphase spindle formation was monitored 
by the addition of rhodamine labeled tubulin in both mock- and B-Raf-depleted extracts.  
Formation of spindles in mock-depleted egg extracts occurred properly, as shown, 
exhibiting bipolar spindles with focused poles and well-organized microtubules (Fig. 20).  
In contrast, the depletion of B-Raf from egg extracts disrupted spindle assembly, resulted 
in unfocused spindle poles and splayed spindle structures.  Several monopolar, half 
spindle structures were also formed as well as structures lacking organized microtubules 
and containing misaligned chromosomes.  These results indicate that B-Raf is required 
for mediating proper spindle assembly in Xenopus egg extracts.   
  
 
 
                         
                                                                    
 
 Figure 19  Immunodepletion of B-Raf from 
Xenopus egg extracts 
CSF-arrested Xenopus egg extracts were depleted of 
endogenous B-Raf protein with B-Raf specific 
antibodies.  Extracts were activated into S phase (S) 
with 0.4 µM Ca+2 addition and cycled into M phase 
(M) with nondegradable cyclin B.   
 
 
 
 
 
 
 
 
                                                                       
Figure 20  B-Raf contributes to spindle assembly 
in Xenopus egg extracts 
Extracts were prepared as in figure 20.  Rhodamine 
labeled α-tubulin was added to visualize spindle 
assembly and DNA was stained with Hoechst buffer.  
Images were taken on 100X magnification. 
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B-Raf is Necessary for Spindle Formation and Chromosome Congression in Human 
Somatic Cells 
 Our preliminary studies in Xenopus egg extracts suggest a role for B-Raf in the 
regulation of mitotic spindle assembly.  Immunofluorescence data suggests that active 
forms of B-Raf reside at mitotic structures in human somatic cells.  Therefore I 
investigated whether B-Raf regulates the assembly of the mitotic spindle in human 
somatic cells.  
 
Knockdown of B-Raf by siRNA Inhibits Proper Spindle Formation and Chromosome 
Congression  
To determine if B-Raf regulates spindle assembly in human somatic cells, two 
independent 21-base pair RNA duplexes corresponding to conserved B-Raf sequences in 
exon 11 (BE11), and exon 3 (BE3) were utilized to downregulate B-Raf .  Spindles of 
mitotic cells were subsequently analyzed via immunofluorescence microscopy.  siRNAs 
were transfected individually into human foreskin fibroblast (HFF) cells and HeLa cells 
(data not shown).  A 21-base pair scrambled sequence was used as a control.  
Transfection of the BE11 or BE3 siRNAs led to an 80-95% reduction of B-Raf protein 
levels in HFF cells within 72 hours as assessed by immunoblot (Fig. 21).  The scrambled 
control siRNA had no apparent effects on spindle morphology (Fig. 22).  However, 
knockdown of B-Raf with the BE11 or BE3 siRNA resulted in pleiotropic spindle 
abnormalities in 80-90% of the mitotic cells analyzed from at least eight independent 
experiments.  Three general groups of abnormal spindle phenotypes were observed:  49% 
with abnormal spindle morphology, including unfocused poles, 29% with shortened 
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spindle structures, and 22% with microtubule bundles.  In the scrambled control cells, 
chromosome congressed in an organized, linear fashion at the metaphase plate in nearly 
90% of cells. In contrast, chromosome alignment at the metaphase plate was perturbed in 
the vast majority of B-Raf depleted cells.  Cells exhibited chromosomes throughout the 
region of the metaphase plate, along the perimeter of the mitotic spindle structures, at the 
spindle poles, and encircling entire spindle structures.  Thus, our data suggest that B-Raf 
is critical for proper spindle formation and chromosome congression in human somatic 
cells.  
 
C-Raf is Dispensable for Normal Spindle Assembly 
 Previous studies suggested that C-Raf (Raf-1) might play a cell cycle role at the 
G2/M transition [118, 284, 285].  Therefore, we also examined the consequences of 
reducing C-Raf protein levels in HFF cells.  We transfected a 21-base pair RNA duplex 
(siRNA) specifically targeting C-Raf into human foreskin fibroblast (HFF) cells.  A 21-
base pair scrambled sequence was used as a control.  Transfection of HFF cells with the 
C-Raf specific siRNA led to an 85% or greater reduction of C-Raf, but not B-Raf, after 
48-72 hr (Fig. 23, A).  In contrast to the phenotypic abnormalities generated in B-Raf 
knockdown cells, spindle morphology and chromosome alignment appeared completely 
normal in C-Raf depleted HFF cells as evaluated by immunofluorescence microscopy 
(Fig. 23, B).  Thus, we conclude that C-Raf is not required for proper spindle formation 
or chromosome congression in somatic tissue culture cells. 
  
 
 
 
 
 
 
 
 
 
   
 
 
 
 Figure 21  Downregulation of B-Raf by siRNAs   
HFF cells were transfected with scrambled siRNA 
(SCR) or siRNAs targeting sequences within 
exons 11 or 3 of B-Raf (BE11 or BE3, 
respectively) and analyzed 48-72 hours post-
transfection.  Western analysis probing for B-Raf 
or α-tubulin (loading control).   
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Figure 22  B-Raf contributes to proper spindle assembly in human somatic cells 
HFF cells were transfected with scrambled siRNA (SCR) or siRNAs targeting B-Raf (BE11 or BE3) and 
analyzed 72 hours post-transfection.  Photos are representative of typical abnormalities observed in spindle 
(red) morphology and chromosome (blue) congression.  50-100 spindle structures were analyzed in each of 
8 experiments for each siRNA.  Images were acquired at 60X magnification; scale bar represents 5 μM.   
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A. 
B. 
Figure 23  C-Raf is not necessary for assembly of 
the mitotic spindle 
Knockdown of C-Raf by siRNA has no effect on 
spindle assembly or DNA alignment.  HFF cells were 
transfected with a scrambled control siRNA (SCR), B-
Raf specific siRNA, or C-Raf specific siRNA and 
analyzed 72 hours post-transfection.  (A) Western 
analysis probing for C-Raf or α-tubulin (loading 
control).  (B) Mitotic spindle and DNA alignment 
appear normal in C-Raf-depleted cells transfected with 
siRNA.  Results are representative of at least three 
independent experiments.  Images were acquired at 
60X magnification; scale bar represents 5 μM. 
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B-Raf Regulates Microtubule-Kinetochore Engagement 
 Metaphase is the stage of mitosis during which chromosomes align in the 
metaphase plate, equidistant from each centrosome, a process termed chromosome 
congression.  Chromosome congression is preceded by and dependent upon the bipolar 
attachment of spindle microtubules to the kinetochores of each chromosome, otherwise 
known as “microtubule-kinetochore engagement” or “microtubule capture”.  Microtubule 
capture depends on the coordination of proteins which localize to the kinetochores.  
Following the downregulation of B-Raf, cells exhibit aberrancies in both spindle 
assembly and chromosome congression.  One explanation for the lack of chromosome 
congression could be that microtubule-kinetochore engagement is impaired in the 
absence of B-Raf.  The localization data demonstrates that B-Raf localizes to and is 
phosphorylated at the kinetochores, suggesting that B-Raf may indeed play a role in 
kinetochore mediated functions. 
 
CENP-E Levels are Elevated at the Kinetochores in the Absence of B-Raf 
 In order to determine whether the microtubules and kinetochores are engaged 
following siRNA downregulation of B-Raf, cells were analyzed for the presence of an 
engagement marker.  The CENP-E motor protein is essential for microtubule capture by 
kinetochores and for regulating subsequent microtubule-kinetochore dynamics [286].  It 
has also been established that the levels of CENP-E bound to the kinetochores during 
early mitotic stages is increased three to five fold when microtubules are unattached to 
kinetochores [286].  While the significance of this increase is not fully understood, 
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kinetochore associated CENP-E levels serve as a marker of microtubule-kinetochore 
engagement.   
HeLa and HFF cells were transfected with B-Raf or scramble control siRNAs as 
previously described.  72 hours post-transfection, it was determined that the B-Raf 
knock-down cells exhibited the aforementioned phenotypic abnormalities.  A 
corresponding set of scrambled control and B-Raf knock-down cells were subjected to 
immunostaining for CENP-E and the kinetochore marker, CREST.  Cells were imaged 
via confocal microscopy and 3-dimentional z-series projections were used to quantify the 
CENP-E colocalized with the kinetochores.  While CENP-E was present at the 
kinetochores in the scrambled control cells, levels of kinetochore bound CENP-E 
increased by an average of 3.8 fold in cells transfected with the B-Raf siRNA (Fig. 24). 
The B-Raf knock-down cells that were analyzed exhibited chromosomal misalignment. 
 
Microtubules are not Cold Stable in the Absence of B-Raf 
 Cells transfected with B-Raf siRNA display misaligned chromosomes and have 
elevated CENP-E, a marker for impaired microtubule capture.  Microtubule 
polymerization from tubulin dimers is a dynamic and reversible process.  Polymerized 
spindle microtubules are cold-stable when the microtubule’s plus ends are attached to 
kinetochores and conversely they are cold-labile when unengaged.  The classic 
experiment to directly assess whether spindle microtubules are engaged with 
kinetochores is to perform a cold-microtubule depolymerization assay.   
 To do this, I downregulated B-Raf using siRNA as described above and cells 
subsequently were plated on coverslips in tissue dishes.  72 hours post- transfection, 
 
  
 
 
   
Figure 24  Kinetochore bound CENP-E levels following 
downregulation of B-Raf 
Quantitation of CENP-E bound to the kinetochores.  (A)  HeLa cells 
were transfected with a SCR control siRNA or siRNA targeting B-Raf 
(BE11) and 72 hours post-transfection cells were stained for DNA (blue), 
kinetochore (red), CENP-E (green).  (B)  CENP-E that localizes directly 
with kinetochores was quantified. 
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the tissue culture dishes on which the cells were plated were subjected to cold by 
incubation on ice for several minutes.  Cells were then fixed, stained for alpha-tubulin 
and DNA, and their microtubules were analyzed by immunofluorescence microscopy.  
The scrambled control cells exhibited normal chromosome congression spindle assembly 
(Fig. 25).  Following cold treatment, the microtubules of the control cells remained 
polymerized.  (The cells exhibited the anticipated morphological changes associated with 
cold).  The cells in which B-Raf was transfected exhibited misaligned chromosomes and 
abnormal spindles.  When subjected to cold treatment nearly 100% of these microtubules 
underwent complete and rapid depolymerization, thus demonstrating an absence of 
kinetochore-microtubule engagement in these cells.
  
 
 
                                  
Figure 25  Microtubules are not cold-stable in the absence of B-Raf 
HFF cells were transfected with a scrambled siRNA (siSCR) or a B-Raf targeting siRNA (siB-
Raf).  72 hours post-transfection cells were exposed to ice for 10 minutes to depolymerize 
unengaged microtubules.  Cells were then fixed with 4% paraformaldehyd and stained for DNA 
(blue) and α-tubulin (green).  B-Raf depleted cells retained few to no polymerized microtubules, 
demonstrating that those cells had few to no microtubules engaged with kinetochores. 
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B-Raf Regulates the Spindle Assembly Checkpoint 
 The spindle assembly checkpoint (SAC) arrests cells in mitosis prior to anaphase 
until all sister chromatid pairs are attached at the mitotic spindle.  Activation of the SAC 
is dependent upon the activities of proteins which localize to the kinetochores.  B-Raf 
itself localizes to and is dually phosphorylated at the kinetochores exclusively during 
mitosis.  B-Raf depleted cells generate abnormal spindle structures and misaligned 
chromosomes and have deficiencies in microtubule-kinetochore engagement.  Regardless 
of such dramatic mitotic defects, B-Raf depleted cells continue to proliferate over a 3-4 
day period similar to control cells treated with scrambled siRNA.  Therefore, we asked 
whether the spindle assembly checkpoint is functional in cells that are lacking B-Raf. 
 
Cells Cycle through Mitosis in the Absence of B-Raf 
 It is anticipated that cells will arrest in mitosis if they have defects in spindle 
assembly.  To address whether B-Raf depleted cells arrest at the spindle assembly 
checkpoint, control and B-Raf depleted cells were counted and scored as being in 
interphase or mitosis based on their flattened or rounded morphology, respectively.  The 
percentage of rounded cells following B-Raf downregulation was not significantly 
increased over cells in the control group (Fig. 26, A).   
 Cyclin B levels peak during metaphase and drop off rapidly to initiate anaphase, 
therefore Cyclin B levels serve as a biochemical marker of mitosis, specifically of 
metaphase.  We analyzed Cyclin B levels, via western blot analysis, in cells transfected 
with the scrambled control siRNA or a B-Raf specific siRNA 72 hours post-transfection.  
 74 
Levels of cyclin B were not increased in the B-Raf depleted cells relative to SCR control 
cells (Fig. 26, B). 
 Together, these data indicate that 72 hours of downregulation of B-Raf does not 
lead to a spindle assembly checkpoint arrest despite the notable induction of spindle 
abnormalities and the impairment of microtubule-kinetochore engagement.    
  
Induced Spindle Assembly Checkpoint is Compromised in the Absence of B-Raf 
 Downregulation of B-Raf drives significant mitotic abnormalities that persist 
without induction of a SAC, suggesting that B-Raf may be necessary for SAC function.  
In order to determine whether B-Raf is required for activation of the SAC, scrambled 
control or B-Raf downregulated cells were subjected to a classic SAC challenge with 
microtubule poisons.   
 HFF and HeLa cells were challenged with nocodazole or taxol in order to induce 
a SAC 48 hours after transfection with scrambled control or B-Raf siRNAs.  After 24 
hours of challenge cells were analyzed for their capacity to arrest in mitosis.  Cells were 
lysed and subjected to western blot analysis to evaluate Cyclin B levels as a biochemical 
marker of a spindle assembly arrest.  Cyclin B level are reduced to nearly undetectable 
levels in cells depleted of B-Raf upon challenge nocodazole or taxol (Fig. 27) confirming 
that an artificially induced SAC is not fully functional in the absence of B-Raf.  Live 
imaging microscopy of taxol treated cells confirmed that scrambled control cells entered 
and remained in a rounded morphological state consistent with the expected induction of 
metaphase arrest, whereas B-Raf depleted cells acquired a flattened morphology 
following a brief rounded state induced by taxol, indicative of a breached arrest (Fig. 28).  
  
 
                                    
Figure 26  Cells do not enter mitotic 
arrest in the absence of B-Raf 
HFF cells were transfected with a 
scrambled or B-Raf targeting siRNA. (A)  
Mitotic cells were scored based on round 
morphology.  (B)  Cells were lysed and 
probed for B-Raf, the mitotic marker, 
cyclin B and total ERK for a reference.  
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Figure 27  Cells do not maintain a spindle 
checkpoint arrest in the absence of B-Raf 
HFF cells were transfected with scrambled or B-
Raf targeting siRNAs for 48 hours followed by a 
nocodazole challenge for 24 hours.  Cells were 
lysed and probed for B-Raf, the mitotic marker, 
cyclin B and total ERK.   
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Time spent in mitosis 
Time spent in mitosis 
Figure 28  B-Raf depleted cells exit mitotic arrest in the presence of 
taxol 
HeLa cells were transfected with scrambled control or B-Raf targeting 
siRNAs for 48 hours and then treated with 50nM taxol in 0.1% DMSO 
for 24 hours during which time cells were imaged using live imaging 
phase contrast microscopy.  (A)  20 (SCR) or 17 (BE11) individual 
cells were analyzed for their time spent in mitosis.  (B)  On average, B-
Raf depleted (BE11) cells spent significantly less time in mitosis 
relative control cells.
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Figure 29  Cells prematurely exit metaphase 
in the absence of B-Raf 
HeLa cells were transfected with scrambled or 
B-Raf siRNAs for 48 hours and live imaging 
performed for the following 24 hours.  (A) 
Images were collected every 1 min over a 24 hr 
period at 20X magnification.  Mitosis starts at 
nuclear envelope breakdown (NEB) and ends 
at cytokinesis.  The data was compiled from at 
least 35 cells per condition from 2 independent 
experiments and is graphed (B) as the average 
+/- standard error.  
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B-Raf Depleted Cells Exit Metaphase Prematurely 
 To directly test whether the SAC is compromised in B-Raf depleted cells, 
scrambled control or B-Raf depleted HeLa cells were subject to live imaging phase-
contrast microscopy for 24 hours.  The total duration of mitosis was scored from nuclear 
envelope breakdown (NEB) through cytokinesis.  HeLa cells treated with B-Raf siRNA 
accelerated faster through mitosis than SCR control cells, averaging 66 vs. 83 min, 
respectively (Representative photo Fig. 29, A).  Closer inspection revealed that B-Raf-
depleted cells remained in metaphase on average 24 minutes less than non-depleted cells 
(Fig. 29, B).  In contrast, timing through anaphase-telophase was not significantly 
affected in B-Raf siRNA-treated HeLa cells, although a modest delay in cytokinesis was 
consistently observed.  These results, imply that the spindle checkpoint is suppressed in 
HeLa cells depleted of B-Raf.   
 
Kinetochore Localization of Mad2 and Bub1 is Inhibited in the Absence of B-Raf  
 Published data in Xenopus egg extracts has indicated ERK signaling regulates the 
requisite kinetochore localization of key spindle assembly checkpoint proteins.  Since B-
Raf’s only known functions are regulated via ERK, we postulated that B-Raf regulates 
localization of SAC proteins to the kinetochores.  To test this possibility, kinetochore 
localization of spindle checkpoint proteins Bub1 and Mad2 was analyzed in control and 
B-Raf depleted cells.  To do this, metaphase chromosomes were isolated from colcemid-
treated HeLa cells, immunostained for the kinetochore marker, CREST, and Bub1 or 
Mad2.  In chromosomes isolated from scrambled siRNA transfected cells, localization of 
Bub1 and Mad2 at CREST-stained kinetochores was readily detectable (Fig. 30).  In 
  
 
     
 
       
 
Figure 30  Mad2 and Bub1 kinetochore localization is inhibited in the 
absence of B-Raf 
HeLa cells were transfected with a scrambled (SCR) or B-Raf specific 
(BE11) siRNA for 72 hours prior to chromosomal isolation.  Kinetochore 
localization of Bub1 (B) and Mad2 (C) was analyzed using 
immunofluorescence on isolated chromosomes.  DNA is stained with DAPI 
(blue), kinetochores are stained with CREST (red), Bub1 and Mad2 are 
shown in green. 
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contrast, Bub1 and Mad2 immunostaining was greatly diminished or undetectable at the 
kinetochores of HeLa cells treated with the B-Raf siRNA, demonstrating that B-Raf is 
necessary for proper localization of critical spindle assembly checkpoint proteins, Bub1 
and Mad2.  Since kinetochore localization of spindle checkpoint proteins is an indication 
of SAC activation, we conclude that B-Raf is critical for SAC activation.   
 
Conclusions 
 Our lab previously demonstrated that B-Raf regulates MAPK signaling during 
mitosis in Xenopus egg extracts.  However, B-Raf had no known functional role in 
mitosis in Xenopus egg extracts or in mammalian cells.  The work described in this 
chapter demonstrates that B-Raf is necessary for proper spindle assembly in Xenopus egg 
extracts and in human somatic cells.  Chromatin congression is severely impaired upon 
B-Raf downregulation in human cells and we show evidence suggesting that 
microtubules are not fully engaged with the kinetochores in the absence of B-Raf.  While 
such grave mitotic errors ought to elicit a spindle assembly checkpoint arrest, I have 
demonstrated B-Raf depleted cells accelerate faster through mitosis and bypass the 
spindle assembly checkpoint.  We conclude that B-Raf contributes to several critical 
mitotic functions including spindle assembly, chromatin congression, microtubule 
capture and activation of spindle assembly checkpoint.   
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CHAPTER 4 
ONCOGENIC B-RAF DISRUPTS MITOSIS AND CAUSES CHROMOSOMAL 
INSTABILITY 
 
Introduction 
 Mutationally activated B-Raf is detected in ~8% of human cancers with a 
particularly high frequency in melanoma (60-70%), colorectal (15-20%), papillary 
thyroid (35-50%), and ovarian (30%) cancers [216, 217, 287-291].   The B-RafV600E 
mutant accounts for at least 90% of all B-Raf mutations detected to date which renders B-
Raf into a constitutively active state [216, 224].  As such, B-RafV600E sustains 10-fold 
higher levels of ERK activity in melanoma cells [292].  Ectopic B-RafV600E expression 
transforms immortalized NIH 3T3 fibroblasts and mouse melanocytes in culture [216, 
223, 226, 293, 294] and is required for melanoma cell proliferation, survival, and 
melanoma tumor growth and vascular development in vivo [226, 295, 296].  Together, 
these finding underscore crucial roles for B-Raf in tumorigenesis.  How oncogenic B-Raf 
is required for tumorigenesis remains poorly understood.  Part of the transforming 
activities of B-RafV600E may occur through subverting adhesion-dependent G1 phase 
controls for cyclin D1 expression and p27 down-regulation [297, 298] and suppressing 
anoikis in melanoma cells [299, 300].     
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Aneuploidy is a widely recognized trait of many human cancers and is associated 
with tumor progression and poor prognosis [301, 302].  Aneuploidy results from mitotic 
errors in chromosome segregation due to defects in the spindle assembly checkpoint 
(SAC) and centrosome amplification [242, 303].  It is widely believed that aneuploidy 
itself can be a transforming event through the generation and selection of chromosomal 
profiles that favor cell growth, resistance to cell death and metastatic potential.  Human 
melanomas are highly aneuploidy.  In fact, changes in DNA copy number are detected in 
greater than 95% of human primary melanomas [304, 305] suggesting that early 
oncogenic events contribute to the onset of aneuploidy.   
We have demonstrated that B-Raf regulates mitotic functions that are required to 
ensure proper chromosomal segregation and the genomic fidelity of the cell.  In this 
chapter, we explore the possibility that the most common oncogenic mutation in B-Raf, 
V600E, contributes to mitotic defects leading to the acquisition of aneuploidy.   
 
Results 
B-RafV600E Expression Promotes Mitotic Abnormalities in Melanoma Cells 
 B-Raf plays a critical role in the regulation of spindle formation, microtubule-
kinetochore engagement and activation of the spindle assembly checkpoint in human 
somatic cells.  This prompted us to ask whether the constitutively active oncogenic form 
of B-Raf, carrying a V600E mutation, might have adverse effects at mitosis.   
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B-RafV600E Status in Melanoma Cells is Associated Mitotic Abnormalities 
 To address the possibility that B-RafV600E may have adverse effects on mitosis, 
mitotic events in A375 and SK-MEL28 melanoma cells, that are known to harbor B-
RafV600E mutations, were analyzed by immunofluorescence microscopy.  In parallel, we 
examined mitoses in WM35, SbCl2, and SK-MEL5 melanoma cell lines expressing wild 
type B-Raf.  Normal mitotic spindles were detected in at least 90% of the mitotic figures 
examined in melanoma cells with wild type B-Raf (Fig. 31).  In contrast, abnormal 
spindles with misaligned chromosomes were observed at a high frequency (70-85%) in 
both A375 and SK-MEL28 cells (Fig. 31).  These results indicate that melanoma cells 
carrying B-RafV600E mutations are more prone to forming aberrant mitotic spindle 
structures during cell division.     
 
B-RafV600E Promotes Spindle Abnormalities and Centrosome Amplification in Human 
Melanoma Cells 
 Based on the correlative findings between oncogenic B-Raf expression and 
mitotic abnormalities, we hypothesized that the constitutively active B-RafV600E mutant 
was responsible for causing the abnormal mitoses observed in the mutant B-Raf 
melanoma cells.  In experiments carried out in the Guadagno lab, by Yongping Cui, B-
RafV600E was introduced into SK-MEL-5 human melanoma cells with a wild type B-Raf 
background.  Cells were infected via a retrovirus using a pBabe-puro-B-RafV600E vector 
or the corresponding empty vector control.  Expression of the recombinant B-RafV600E 
mutant was confirmed by western analysis (Fig. 32, A) and led to elevated phospho-ERK 
levels as previously reported [306].  Strikingly, SK-MEK-5 melanoma cells transduced 
  
 
      
 
 
 
 
       
Figure 31 Aberrant chromatin congression in B-RafV600E positive 
melanoma cells 
Panel of human melanoma cell lines during mitosis containing wild type (WT) 
or mutant (V600E) B-Raf.  Microtubule spindles and DNA were detected by 
staining with a α-tubulin antibody and DAPI, respectively.  Magnification is 
63X. (B) Graphs show the percent of normal versus abnormal spindles in 
human melanoma cells at mitosis (n=200).   
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Figure 32  Aberrant mitotic spindle formation and chromatin congression 
in melanoma cells ectopically expressing B-RafV600E  
SK-MEL5 melanoma cells were transfected with pGST, pGST-B-Raf, or pGST-
B-RafV600E plasmid DNAs.  (A) Western blot analysis and (B) 
immunofluorescence staining of mitotic spindles and centrosomes.  DNA was 
detected by DAPI staining.  (C)  Graph of data from Sbcl2 and SK-MEL5 cells. 
200 mitotic figures were analyzed for each condition per experiment.  Scale bar, 
5 μM. 
This figure was contributed by Yongping Cui, Ph.D. 
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with pBabe-B-RafV600E, but not with pBabe alone (empty vector), displayed pleiotropic 
spindle abnormalities in ~76% of mitotic figures examined by fluorescence microscopy 
(Fig. 32, B & C).  These abnormalities include abnormal spindle morphology, multi-polar 
spindles and misaligned chromosomes.  Similar results were obtained in SbCl2 
melanoma cells transfected with pGST-B-RafV600E constructs but not pGST empty vector 
(data not shown).  The abnormal spindle phenotypes were not due to over-expression of 
B-Raf protein per se as ectopic expression of wild type B-Raf in SK-MEL5 cells had 
little effect on spindle formation.  Hence, expression of constitutively active B-RafV600E 
promotes spindle abnormalities in melanoma cells. 
Abnormal numbers of centrosomes often arise in tumor cells resulting in multi-
polar aberrant spindle structures [303].  A portion of mitotic spindles displayed multiple 
poles in melanoma cells transfected with B-RafV600E (Fig. 32, B).  To confirm whether 
this reflects the presence of extra centrosomes, parental and B-RafV600E-modified 
melanoma cells were subjected to immunostaining with an anti-γ-tubulin antibody.  
Depending on the phase of the cell cycle, G1 (unduplicated) or G2 (duplicated) 
centrosomes were typically detected in either parental or vector control SK-MEL-5 cells 
with fewer than 5% containing greater than 2 centrosomes (Fig. 32, C).  In contrast, 
supernumerary centrosomes (as indicated by γ-tubulin stained foci) were detected in 
~30% of interphase cells for both SbCl2 and SK-MEL5 cell lines containing the B-
RafV600E mutant.  Co-staining of microtubules with a α-tubulin antibody revealed 
multipolar spindles at mitosis in cells containing supernumerary centrosomes.  This 
represented about half of the abnormal spindles.  The remaining abnormal spindles 
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contained two centrosomes suggesting that B-RafV600E also perturbs spindle formation 
independent of centrosome amplification.     
 
B-RafV600E Drives Aneuploidy and Chromosome Instability in SbCl2 Melanoma 
Cells 
 The results shown here demonstrate that exogenous B-RafV600E expression 
promotes spindle abnormalities and centrosomal amplification in human melanoma cells.  
While a large number of these cells die, some of these cells are retained in the population 
despite the severity of mitotic abnormalities. It stands to reason that errors in 
chromosome segregation errors may have occurred in these cells, leading to aneuploidy.  
Since these experiments demonstrate that B-RafV600E drives mitotic abnormalities in cells, 
which continue to divide, I decided to determine if the chromosomal composition of these 
cells is changing over time.  Such insights are significant since chromosomal instability 
gives rise to a karyotypically varied population of cells thereby providing a pool for 
selection of cells that have tumorigenic and metastatic potential.   
 
B-RafV600E Induces Aneuploidy in SbCl2 Melanoma Cells  
Most tumor cells and cell lines exhibit aneuploidy, therefore I screened several 
melanoma cell lines for their chromosomal number via metaphase spread analysis.  
SbCl2 cells isolated from an early primary tumor are genomically stable with a mode of 
46 chromosomes (Fig. 33).  In order to test whether B-RafV600E can induce aneuploidy in 
this genomically stable cancer cell line, cells were retrovirally infected with a pBabe-B-
RafV600E vector or the corresponding empty vector control and positively expressing cells  
  
 
                        
B. 
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Figure 33  SbCl2 melanoma cells are near diploid 
(A)  Metaphase spreads were performed on SbCl2 cells and the chromosomes were stained with DAPI and 
pseudocolored green for contrast.  (B)  50 metaphase spreads were counted and the chromosomal 
distribution s are shown.  The upper panel indicated the number of chromosomes each cell contains and the 
lower panel shows the percentage of cells containing 46 chromosomes or <>46 chromosomes.   
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were selected for two weeks in puromycin containing media.  Immunofluorescence and 
western blot analysis was performed to confirm exogenous B-Raf expression and 
activation of ERK (Fig. 34, A & B).  Fluorescence in situ hybridization (FISH) was 
performed on the cells to evaluate their ploidy.  In the empty vector control cells, 5.5% 
and 9.5% of interphase nuclei displayed less than or greater than two signals for 
centromere probes to chromosomes 2 or 8, respectively (Fig. 35, A), which is consistent 
with SbCl2 having a mode of 46 chromosomes.  In contrast, B-RafV600E expressing SbCl2 
cells exhibited aneuploidy at a frequency of 16.5% in chromosome 2 and 20.5% in 
chromosome 8 in (Fig. 35, A).  This data demonstrates a role for constitutively active B-
RafV600E in promoting aneuploidy in tumor cells.   
 
B-RafV600E Drives Chromosome Instability in SbCl2 Melanoma Cells 
 B-RafV600E expression causes significant levels of aneuploidy in SbCl2 melanoma 
cells as demonstrated via FISH analysis.  It is anticipated that the persistence of spindle 
abnormalities in these cells would continue to generate segregation errors and perpetually 
change the chromosomal content of the cells.  Therefore, SbCl2 cells were used to test 
whether B-RafV600E expression can induce chromosomal instability.  SbCl2 cells were 
retrovirally infected and selected for expression of B-RafV600E or an empty vector control 
as described above.  The karyotypes of individual cells were evaluated to assess the 
precise number of chromosomes per cell.  To evaluate the karyotype, metaphase spreads 
were prepared, chromosomes were stained with DAPI and counts were performed on 100 
cells per sample.  A mode of 46 chromosomes was observed in the vector control SbCl2 
cells two weeks post-infection (Fig. 35, B).  As expected in cell culture 50% of the 
  
 
 
      
 
   
       
 
 
Figure 34  Exogenous expression of B-RafV600E in SbCl2 cells 
Retroviral expression of B-RafV600E or empty vector control in SbCl2 melanoma cells that endogenously express 
WT B-Raf.  (A)  Immunofluorescence staining of DNA (blue), tubulin (red) and B-Raf (green).  Threshold is 
lowered until endogenous B-Raf is undetectable in empty vector control.  (B)Western analysis of cell lysates 
prepared from control (empty vector) or B-RafV600E overexpressing Sbcl2 cells.   
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Figure 35  Aneuploidy induced by B-RafV600E in SbCl2 cells 
SbCl2 melanoma cells that endogenously express WT B-Raf were retrovirally infected 
to expression of B-RafV600E or empty vector control.  (A)  Percentage of 200 nuclei 
per condition, that scored positive for aneuploidy by FISH analysis with probes to 
either chromosome 2 or 8.  * p-values for chromosomes 2 and 8 are <0.001 and 
<0.005, respectively. Photos of FISH analysis using centromere probes specific to 
chromosomes 2 (red, 2R) and 8 (green, 8G).  Yellow arrows point to nuclei positive 
for aneuploidy.  (B and C)  Percent distribution and representative examples of 
chromosome numbers obtained from at least 50 metaphase spreads.  Chromosomes 
were detected by staining with DAPI and imaged at 100X magnification.  
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control cells had some degree of aneuploidy, ranging from 29 to 48 chromosomes per 
cell.  In contrast, expression of B-RafV600E resulted in the complete absence of a 
chromosomal mode, with aneuploidy in 94% of the cells (Fig. 35, C).  B-RafV600E 
expressing cells exhibited a large distribution of chromosomes ranging from 15-87 
chromosomes per cell.   These results demonstrate that SbCl2 cells became aneuploid due 
to expression of B-RafV600E.   
 In order to determine if the population of B-RafV600E cells are chromosomally 
unstable, cells were allowed to continue proliferating and their karyotypes were re-
evaluated at later time point.  52% and 48% of the control cells maintained 46 
chromosomes at week four (Fig. 36, A) and week six (Fig. 36, B), respectively, and the 
chromosomal variability ranged from 30 to 51 chromosomes per cell.  Thus the mode and 
the chromosomal variability in the control cells did not change significantly over time.  
B-RafV600E cells continued to be highly aneuploid with only ~5% having 46 
chromosomes.  However, the chromosomal distribution was sharply reduced from 15-87 
chromosomes per cell at two weeks post-infection to 18-52 at four weeks (Fig. 36, C) and 
15-49 at 6 weeks (Fig. 36, D).  This demonstrates that the population of B-RafV600E cells 
is chromosomally unstable with an increase in the percentage of hypoploidy cells over 
time.   
 
 
  
  
 
 
 
 
    
A. 
Figure 36  Change in 
chromosome number 
generated by 4 and 6 
weeks of B-RafV600E  
expression 
SbCl2 melanoma cells 
endogenously expressing 
WT B-Raf were 
retrovirally infected to 
expression of B-RafV600E 
or empty vector control.  
(A)  Karyotype of cells 
cultured for 4 weeks in the 
presence of the pBabe 
puro empty vector.  (B) 
Karyotype of cells 
cultured for 6 weeks in the 
presence of the pBabe 
puro empty vector.  (C)  
Karyotype of cells 
cultured for 4 weeks in the 
presence of the pBabe 
puro B-RafV600E vector.  
(D) Karyotype of cells 
cultured for 6 weeks in the 
presence of the pBabe 
puro B-RafV600E vector.  
50 cells per condition 
were analyzed. 
 
B.
C.
D.
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B-RafV600E Induces Rapid Aneuploidy in Primary Human Cells 
We have demonstrated the emergence of aneuploidy in SbCl2 melanoma cells.  
While this is significant, it raises two important mechanistic questions.  First, B-RafV600E 
positive SbCl2 cells were selected for over a minimum of 2 weeks time.  This could be 
sufficient time for the cells to generate changes which could indirectly be driving 
aneuploidy.  Secondly, SbCl2 cells are already transformed prior to the introduction of 
oncogenic B-Raf, and could therefore possess alterations that allow for the generation 
and survival of aneuploid cells.  Therefore it is important to test whether B-RafV600E can 
induce aneuploidy rapidly in cells of a primary nature.   
 
B-RafV600E Rapidly Induces Aneuploidy in Primary Human Melanocytes 
 In order to determine if B-RafV600E is capable of inducing aneuploidy in non-
transformed cells, we evaluated the potential for oncogenic B-Raf to initiate aneuploidy 
in primary human melanocytes (HEM cells).  Melanocytes are the cell of origin in 
melanoma development.  This is a particularly relevant model considering that B-Raf is 
mutated into its oncogenic form in nearly 70% of melanomas and is mutated 80% of 
benign nevi of melanocytic origin.   
 To examine whether B-RafV600E expression can cause aneuploidy in HEM cells, I 
transiently transfected the cells with the p-Babe-B-RafV600E vector, or the corresponding 
empty vector control, using a high-efficiency, high-viability electroporation transfection 
method.  Transfection efficiency was monitored by visualizing GFP fluorescence of a co-
transfected GFP-containing plasmid and was found to be approximately 90%.  Cells were 
permitted to divide for 96 hours after transfection, the equivalent two cell division cycles, 
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and then subjected to FISH analysis using centromeric probes against chromosomes 3 
and 10.  A low background of 4.5 and 5.5% aneuploidy was observed in non-transfected 
or empty vector (control) transfected cell, respectively (Fig. 37).  Strikingly, 44% of 
nuclei from primary human melanocytes exhibited aneuploidy in either chromosome 3 or 
10 following exogenous expression of B-RafV600E (Fig. 37).  Therefore, we conclude that 
oncogenic B-RafV600E is sufficient to rapidly induce aneuploidy in primary human 
melanocytes. 
 
B-RafV600E Rapidly Induces Aneuploidy in hTERT Immortalized Mammary Epithelial 
Cells 
 While B-Raf is mutated in the vast majority of melanomas, it is as well mutated 
and expressed in its oncogenic form in several other tumor types including colorectal and 
liver cancers, sarcomas and gliomas.  In order to confirm that the induction of aneuploidy 
by B-RafV600E was not specific to HEM cells, I tested the effects of B-RafV600E expression 
in human mammary epithelial cells immortalized with human telomerase (hTERT 
HME1s).  hTERT HME1 cells were transfected and evaluated as described above for 
HEM cells.  As scored via FISH analysis, 7.0 and 6.5% of non-transfected or empty 
vector (control) transfected cells (Fig. 38) are aneuploidy in chromosomes 3 or 10.  
However, hTERT HME1 cells transfected with B-RafV600E exhibited aneuploidy in 39.5% 
of the nuclei, results nearly identical to the results in HEM cells (Fig. 39).  Therefore, we 
conclude that oncogenic B-RafV600E is sufficient to rapidly induce aneuploidy in multiple, 
non-transformed human cell lines. 
  
 
 
 
           
 
A. 
B.
Figure 37  Aneuploidy induced by B-RafV600E in primary human melanocytes 
B-RafV600E or empty vector plasmids were transfected into early passage hTERT-HME1s 96 hours post-transfection, 
interphase FISH analysis was performed using probes to chromosomes 3 (red) and 10 (green), (A) representative 
pictures are shown.  (B) Percent aneuploidy detected in non-transfected (no TF), vector alone (Empty), and B-RafV600E.  
Percent aneuploidy by FISH analysis was calculated from 200 nuclei.  
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Figure 38  Aneuploidy induced by B-RafV600E in immortalized primary human epithelial cells 
B-RafV600E or empty vector plasmids were transfected into early passage hTERT-HME1s 96 hours post-transfection, 
interphase FISH analysis was performed using probes to chromosomes 3 (red) and 10 (green), (A) representative 
pictures are shown.  (B) Percent aneuploidy detected in non-transfected (no TF), vector alone (Empty), and B-RafV600E. 
Percent aneuploidy by FISH analysis was calculated from 200 nuclei.   
A. 
B.
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Conclusions 
 B-Raf is mutated into a constitutively active oncogenic form in an extraordinarily 
high percentage of melanomas and other cancers.  Therefore, understanding the 
mechanisms by which B-Raf elicits its oncogenic effects is of great significance. Prior to 
my work the transforming activities of oncogenic B-Raf have been exclusively limited to 
interphase related roles including cell cycle entry, adhesion controls and resistance to 
anoikis.  The results from this chapter demonstrate for the first time that expression of 
oncogenic B-Raf, V600E, causes mitotic abnormalities when expressed in melanoma 
cells.  B-RafV600E subsequently causes melanoma cells to become aneuploid, and 
destabilizes their genome.  As well, expression of B-RafV600E generates rapid aneuploidy 
in primary human melanocytes and primary immortalized mammary epithelial cells.  
From this data, we conclude that oncogenic B-Raf, V600E, drives mitotic abnormalities, 
aneuploidy and chromosomal instability.    
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CHAPTER 5 
DISCUSSION 
 
 The key discoveries of this dissertation are the novel findings that B-Raf regulates 
critical functions in mammalian cell mitosis, and that oncogenic B-Raf perturbs mitosis 
and directly causes aneuploidy.  Together, the results of my thesis research expand our 
understanding of mitotic regulation and highlight the significance of B-Raf overactivation 
in tumorigenesis. 
 
B-Raf Performs Critical Functions during Mitosis 
In the studies described herein, a combination of immunocytochemistry and RNA 
interference was used to assess potential functions for B-Raf at mitosis in human somatic 
cells.  Immunofluorescence studies demonstrate that B-Raf localizes to key mitotic 
structures.  Consistently, functional studies demonstrate that B-Raf expression is critical 
for allowing proper spindle formation, chromosome congression, microtubule-
kinetochore engagement and spindle checkpoint function.  These are the first studies that 
link B-Raf to mitotic functions in human somatic cells. 
 
MAPK Mitotic Functions 
It has long been known that MAPK signaling regulates several functions in 
mammalian cell mitosis including mitotic entry [111, 117, 118] and exit [130, 131], 
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spindle assembly [115] and Golgi apparatus fragmentation [135, 136, 307].  Studies in 
Xenopus egg extracts have suggested that MAPK regulates the spindle assembly 
checkpoint [73, 129].  However, beyond mitotic entry, a role for the MAPK cascade in 
mammalian cell mitosis had not been firmly established.  Work from our lab 
demonstrated that B-Raf is the MEK kinase that activates the MAPK cascade during 
mitosis in Xenopus egg extracts [180], however, prior to my studies it was not known 
whether B-Raf had functional roles in mitosis. 
 
B-Raf Localizes to the Cytoplasm during Interphase in Human Somatic Cells   
It has long been thought that B-Raf is a cytoplasmic protein that gets transiently 
recruited to the plasma membrane for Ras mediated activation upon stimulation by 
mitogens.  Using epifluorescence, we confirm that during interphase B-Raf exhibits 
cytoplasmic localization, and nuclear exclusion, (Fig. 7).  While cytoplasmic B-Raf 
staining appears to be diffuse, upon close inspection, it appears that B-Raf is most highly 
concentrated in the perinuclear area.  Further, I have found that B-Raf distinctly 
colocalizes with the early endosome during interphase (data not shown).  While we did 
not investigate the significance of these localization patterns, they are consistent with a 
study demonstrating that endosome associated Rap1 activates prolonged MAPK 
signaling through B-Raf in response to neural growth factor (NGF) [308].  It is tempting 
to speculate that within endosomes B-Raf undergoes Rap1 mediated activation.  Further 
analyses would be required in order to make any substantial claims regarding B-Raf’s 
perinuclear and endosomal localization.   
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B-Raf Localizes to Mitotic Structures in Human Somatic Cells 
Prior to the study presented here, B-Raf was thought to reside exclusively in the 
cytoplasm.  Using epifluorescence and confocal microscopy, I show that a portion of B-
Raf becomes associated with distinct mitotic structures in human foreskin fibroblast 
(HFF) cells (Fig. 7, 8).  During prophase, B-Raf undergoes a dramatic relocation to the 
nuclear region, a portion of B-Raf is detected at the spindle apparatus and B-Raf is tightly 
associated with the centrosomes (Figs. 7, 8, 14).  B-Raf’s presence at the spindle is most 
prominent during metaphase at which time it can be detected at the spindle poles, spindle 
microtubules, and kinetochores.  This mitotic staining pattern of B-Raf is not cell line 
specific as we detected similar staining at the mitotic spindle in several other cell lines 
including mouse NIH 3T3 fibroblasts (Fig. 6, 13).  We propose that a portion of B-Raf is 
directly associated with the microtubules during interphase, as seen by the reticular 
perinuclear staining pattern (Fig. 7), and during mitosis as suggested by several 
experiments in human cells and Xenopus egg extracts (Fig. 9, 10, 11).  This would 
account for B-Raf’s re-localization to the prophase nuclear region, where the microtubule 
organizing centers reside, and its enrichment at the metaphase spindle.  B-Raf is enriched 
at the spindle and spindle midzone during metaphase and anaphase, respectively.  
Colocalization of B-Raf to these key mitotic structures suggests that it has a role in 
spindle formation and spindle dynamics during mitosis.  This data indicates that a portion 
of B-Raf is temporally and spatially regulated at the spindle apparatus throughout the 
phases of mitosis.   
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Phosphorylation of Thr599 and Ser602 is critical for Ras-mediated B-Raf 
activation [160].  During interphase phospho-B-Raf (Thr599 Ser602) is largely 
undetectable with the exception of weak centrosomal staining.  At the onset of mitosis, 
however, phospho-B-Raf (Thr599/Ser602) is prominently localized to the nuclear region 
of condensing chromosomes (Fig. 15), which overlaps with the temporary localization of 
active Cyclin B-Cdk1 [309].  Thus, this localization pattern is consistent with the idea 
that mitotic B-Raf is activated in a Cyclin B –Cdk1 dependent manner [181].  Phospho-
B-Raf (Thr599 Ser602) is readily detectable at the centrosomes throughout mitosis.  This 
corresponds to the localization of active forms of MEK and ERK [112, 114].  As well, 
phospho-B-Raf (Thr599 Ser602) is detectable in the region of condensing chromatin 
throughout mitosis and is distinctly localized to the perichromosomal space (Fig. 16, 17).  
B-Raf is also phosphorylated at the midbody during telophase/cytokinesis, likewise, 
active MEK and ERK localize to the midbody during telophase [112, 114].  Activated 
forms of MEK and ERK have also been shown to localize to mitotic kinetochores.  Upon 
inspection of the isolated chromosomes, it is shown that phospho-B-Raf colocalizes 
precisely at the kinetochores of metaphase cells, whereas kinetochore localization is 
absent during interphase (Fig. 18).  These results indicate that pools of B-Raf are active at 
the spindle apparatus during mitosis.  These pools colocalize with active forms of MEK 
and ERK, indicating that B-Raf activates MAPK signaling at discrete mitotic sites.  
Further research is necessary to determine whether different mitotic B-Raf is activated in 
one location and transported to various destinations or if the pools are independently 
activated.   
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The kinase that phosphorylates B-Raf at the Thr599 Ser602 residues is unknown.  
It would be interesting to determine whether phosphorylation of B-Raf is executed by the 
same kinase throughout interphase and mitosis.  Interestingly, work performed in the cell-
free system of Xenopus egg extracts showed that Cyclin B-Cdk1 directly associates with 
and phosphorylates Xenopus B-Raf at a Ser144 [181], a site conserved in human B-Raf.  
This phosphorylation event is necessary, but not sufficient for its activation at mitosis.  
Development of phospho-Ser144 specific antibodies will help to elucidate whether this 
phosphorylation occurs in somatic cells and whether B-Raf phosphorylated at Ser144 
associates with mitotic structures. 
 
Our results showing that pools of active B-Raf on mitotic structures  are in 
agreement with a previous study detecting a small peak of B-Raf activity at mitosis of 
synchronized HeLa cells [134].  Taken together, these data suggest that B-Raf may 
function during mitosis in human somatic cells.  Specifically, these data imply that during 
mitosis B-Raf may be involved in regulating spindle assembly and spindle, chromosome 
condensation, microtubule-kinetochore attachment, the spindle assembly checkpoint, 
anaphase and cytokinesis.  Although it was not addressed in my thesis studies, I observed 
a pronounced distribution of B-Raf in the region around the mitotic spindle, which may 
overlap with the localization of the fragmented Golgi and endoplasmic reticulum during 
mitosis.  Therefore, it is possible that B-Raf as well activates ERK signaling necessary 
for mitotic fragmentation of Golgi network.   
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B-Raf Regulates Mitotic Functions in Human Somatic Cells  
 B-Raf’s mitotic localization is strongly suggestive of a functional role during 
mitosis.  In my thesis studies, I tested whether B-Raf functions at mitosis in human cells 
by using siRNA to selectively deplete B-Raf from cells.  Knockdown of B-Raf, but not 
Raf-1, had pleiotropic effects on spindle formation and chromatin congression in human 
somatic cells (Fig. 22, 23).   
 A minimum of 80% of the mitotic figures examined from B-Raf-depleted cells 
display various spindle abnormalities including unfocused spindle poles and alterations in 
spindle morphology (Fig. 22).  Corroborating these results is immunofluorescence 
detection of B-Raf at various structures of the spindle apparatus during mitosis.  A 
portion of B-Raf appears to interact directly with the spindle microtubules and a pool of 
B-Raf is detectable specifically at the centrioles after pre-extraction with CHAPS 
detergent (Fig. 14).  However, reduction of B-Raf did not appear to have an effect on 
centrosome duplication or separation (unpublished observations).   Instead, a high 
frequency (40-50%) of aberrant spindles with unfocused poles was observed.  Similarly, 
Xenopus egg extracts treated with the MEK inhibitor, U0126 exhibited several 
phenotypically abnormal spindle structures including monastral structures lacking 
condensed chromatin [115].  Together, these findings support a possible role for the B-
Raf/MEK/ERK pathway in mediating spindle pole focusing.  This might occur through 
regulation via ERK-mediated phosphorylation of one of the various regulators implicated 
in spindle pole functions including dynein, NuMA, Aurora A, and Xklp2.  Alternatively, 
B-Raf signaling may target structural components of the centrosome that are necessary 
for the maturation or focusing of spindle poles.     
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 Chromosome alignment at the metaphase plate was dramatically altered in the 
majority of B-Raf-depleted cells (Fig. 22).  As well, NIH3T3 cells treated with the U0126 
inhibitor exhibited abnormal spindles including those with unattached chromosomes 
[115]. Chromosome alignment is dependent upon microtubule capture and the subsequent 
countering forces that pull chromosomes poleward.  Thus, the observation that 
chromosomes are misaligned in the absence of B-Raf could be due to direct defects in 
microtubule-kinetochore engagement.  Alternatively or additionally, chromosomal 
misalignment could manifest as a result from a precipitous exit from metaphase, in other 
words, a defective SAC that gives insufficient time for proper chromosome congression.  
In accordance with both of these options, phospho-B-Raf (Thr599/Ser602) is readily 
detectable at mitotic kinetochores (Fig. 18), the site of microtubule engagement and the 
SAC.   
 
 Through analysis of a marker for impaired microtubule-kinetochore engagement, 
my data indicates that microtubules are not engaged with kinetochores in the absence of 
B-Raf (Fig. 24) and this is confirmed through direct analysis of the microtubule-
kinetochore attachments (Fig. 25).  CENP-E is the only protein identified to date that 
directly facilitates microtubule-kinetochore engagement.  Thus, it can be proposed that B-
Raf signaling governs CENP-E’s mitotic functions.  Indeed, it is known that mitotic 
phosphorylated MAPK interacts with CENP-E and that MAPK can phosphorylate CENP-
E on sites that regulate CENP-E’s interaction with microtubules [114].   
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 Another possible mechanism by which B-Raf affects chromosome congression is 
that B-Raf regulates the duration of metaphase, necessary for permitting proper 
chromosomal alignment.  Indeed, results from imaging mitotic progression in live cells 
depleted of B-Raf support this possibility.  On average, B-Raf siRNA treated cells 
entered anaphase 24 min earlier than control SCR-treated cells, displaying a 33% 
reduction in the duration of the prometaphase/metaphase period (Fig. 29).   
 
 Despite the absence of microtubule-kinetochore attachments and chromosome 
misalignment, B-Raf depleted cells continue to divide for at least 120 hours with no 
indication of widespread mitotic arrest (Fig. 26).  These observations suggest that the 
SAC is defective in the absence of B-Raf.  Bub1 and Mad2 are critical spindle checkpoint 
proteins, whose kinetochore localization is a strong indicator of spindle checkpoint 
activation [286].  As shown in figure 31, kinetochore localization of Bub1 and Mad2 is 
blocked upon B-Raf depletion.  Furthermore, B-Raf depleted cells do not maintain an 
SAC when challenged with taxol (Fig. 28) and live-cell imaging showed that the 
depletion of B-Raf leads to a shortening of the period from prometaphase to anaphase, 
which is consistent with having a defective spindle checkpoint (Fig. 29).  These results 
strongly implicate B-Raf as a regulator of the SAC.     
Mps1 is an essential component of the SAC network [310, 311] and functions to 
localize spindle-checkpoint proteins Bub1, Mad1, and Mad2 to unattached kinetochores 
[70, 73, 310].  Interestingly, it was shown that the Xenopus homologue of Mps1 is 
phosphorylated by MAPK in Xenopus egg extracts at Serine-844, and this 
phosphorylation is necessary for kinetochore localization of Mps1 and other spindle 
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checkpoint proteins [73].  Importantly, recent data from our laboratory demonstrates that 
Mps1 is indeed a target of B-Raf signaling [312].  Specifically, it was shown that B-Raf 
associates with Mps1 in vivo and directs its MAPK-dependent phosphorylation and 
kinetochore localization during mitosis.  Therefore, we speculate that B-Raf mediated 
phosphorylation of Mps1 is important for spindle checkpoint functions.  While beyond 
the scope of this study, it will be important to dissect the contributions of phosphorylation 
events that regulate mitotic functions of Mps1.  Finally, MAP kinase has been reported to 
phosphorylate other critical regulators of the spindle checkpoint, Bub1 [313] and Cdc20 
[129], indicating that B-Raf signaling at mitosis may target multiple components of the 
spindle checkpoint network via MAPK. 
 
We propose that B-Raf elicits its mitotic effects through MAPK signaling.  This is 
supported by the colocalization of B-Raf, MEK and ERK to the spindle poles and 
kinetochores.  However, we cannot preclude the possibility that B-Raf may have MAPK 
independent mitotic functions.  This could be addressed by analyzing B-Raf’s mitotic 
functions in cells with compromised MEK1/2, the only identified down-stream target of 
B-Raf which directly activates ERK 1/2. 
B-Raf signals through MAPK to regulate gene transcription during interphase.  
Therefore, it can be proposed that B-Raf indirectly affects spindle assembly and 
chromosome congression rather than having a direct effect on mitosis.  To address this 
question, we utilized Xenopus egg extracts where B-Raf and MAPK activities are strictly 
limited to mitosis.  Indeed, B-Raf depletion from Xenopus egg extracts results in dramatic 
effects on spindle assembly and DNA alignment (Fig. 20), suggesting that B-Raf directly 
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regulates mitosis in this system.  Together with the localization of B-Raf to mitotic 
structures cell culture, we propose that B-Raf directly regulates mitosis in mammalian 
cells.  
Besides its kinase activity, B-Raf may also function as a scaffold protein.  Based 
on results shown here, we cannot exclude that some or all of B-Raf’s mitotic functions 
are executed via scaffolding capacity.  To address this concern directly, one would need 
to compare WT and kinase dead B-Raf-driven mitotic phenotypes in cells depleted of 
endogenous B-Raf. 
 
In summary, our results reveal several mitotic roles for B-Raf including proper 
spindle formation, chromatin congression, microtubule capture, and the spindle assembly 
checkpoint.  It is feasible to propose that these functions are all independent or 
interdependent.  In the most interdependent example, one could suggest that B-Raf is 
necessary for proper functioning of the SAC, in the absence of which, microtubule 
capture is mitigated, thereby inhibiting chromosome congression and perturbing the 
arrangement of spindle microtubules.  However, since B-Raf localizes to several key 
mitotic structures including the kinetochores, centrosomes and microtubules, I would 
propose that mitotic B-Raf signaling is important for regulating several mitotic functions 
through independent mechanisms.  For instance, B-Raf signaling may regulate the SAC 
through Mps1 and microtubule-kinetochore attachment through CENP-E.  A thorough 
analysis of MAPK substrates at mitosis would potentially reveal other effectors of B-Raf 
signaling that regulate its mitotic functions.   
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Spindle assembly, chromatin congression and the SAC are all critical mitotic 
elements necessary for proper chromosome segregation.  While I did not perform 
karyotype analysis on B-Raf depleted cells, it is likely that these cells become aneuploid 
and chromosomally unstable.  The demonstration that B-Raf regulates critical mitotic 
functions opens a new avenue in addressing how oncogenic B-Raf contributes to 
tumorigenesis.  
 
Oncogenic B-Raf Deregulates Mitosis Causing Aneuploidy and Chromosomal 
Instability 
Aneuploidy is a hallmark of cancer and it is associated with tumor progression 
and poor clinical prognosis [301, 302] and has a causal role in tumorigenesis [263, 277, 
314].  As described previously, B-Raf is overactivated in the majority of human 
melanomas [216].  My studies presented in this section, demonstrate that the main 
activating B-Raf mutation deregulates mitosis and provokes aneuploidy.   
 
Cellular Effects of Oncogenic B-Raf 
The vast majority of oncogenic B-Raf mutations cause constitutive activation of 
the MAPK cascade.  Prior to and during my thesis studies, a variety of experiments have 
revealed several cellular roles through which B-RafV600E may elicit its oncogenic effects 
including cell survival, anchorage independent cell cycle progression, and invasion.  
However, the question of how B-Raf contributes to tumorigenesis is not fully understood.   
Soon after the 2002 discovery that B-Raf is mutated in a wide variety of tumors, it 
was demonstrated that oncogenic B-Raf, specifically B-RafV600E, is necessary for cell 
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survival in B-RafV600E expressing cells.  siRNA and shRNA-mediated downregulation of 
B-RafV600E causes  inhibition of ERK signaling and induces cell cycle arrest and apoptosis 
in cultured cancer cells [225, 226, 315].   
Normal cells require adhesion for signaling and survival [316].  Loss of adhesion 
causes normal cells to undergo anoikis, whereas tumor cells develop the capacity to resist 
anoikis [317].  B-RafV600E expression is necessary for anoikis resistance in melanoma 
cells [299] and this is dependent on B-RafV600E’s negative regulation of pro-apoptotic 
proteins Bad and Bim [300].   
In addition to anoikis, normal cells die when they are subjected to a low-oxygen 
environment.  In contrast, the central tumor zone is hypoxic and tumor cells must evolve 
mechanisms for survival under such conditions [318].  It has been shown that B-RafV600E 
induces expression of hypoxia inducible factor-1α (HIF-1α) and its expression is essential 
for melanoma cell survival in a hypoxic tumor-like environment [319].  Together, these 
data demonstrate that B-RafV600E mediates survival in melanoma cells.  
In addition to cell survival, B-RafV600E appears to regulate cell cycle progression 
in an anchorage independent manner.  In normal human melanocytes, anchorage to an 
extracellular matrix is necessary for growth factor activation of ERK1/2, which leads to 
induction of cyclin D1 and downregulation of p27Kip1, both key events in G1 to S phase 
progression [298, 320].  B-RafV600E expression in melanoma cells causes constitutive 
expression of cyclin D1 and down regulation of p27Kip1, in the absence of cellular 
adhesion and growth factors [297].  Growth arrest concurrent with a decrease in 
expression of cyclins D1 and D3 was observed following downregulation of B-RafV600E 
in human melanoma cells [226, 298].  Brn-2, a transcription factor involved in the 
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proliferation of melanoma cells [321], was also downregulated following siRNA 
mediated reduction of B-RafV600E [322].   
Besides its role in progression from G1 to S phase, recent evidence suggests that 
B-RafV600E regulates the G2 to M phase progression.  Required for melanoma growth is 
Skp2 [297], an E3 ubiquitin ligase that targets multiple proteins for degradation, thus 
promoting the G2-M phase transition [323-328].  In melanoma cells B-RafV600E induces 
expression of Skp2, suggesting that B-RafV600E mediates entry into mitosis [329]. 
A hallmark feature of tumor cells is the acquired ability to invade nearby tissues 
[330].  It has been shown that B-RafV600E upregulates expression of several matrix 
metalloproteinases (MMPs) [331, 332], which are known to mediate invasion through 
cleavage of extracellular matrix components [333].  Using a matrigel assay, it was shown 
that downregulation of B-RafV600E decreases the invasive potential of PTCs.  
Additionally, it has been demonstrated that the actin cytoskeleton and focal adhesion in 
melanoma cells is disrupted by B-RafV600E expression through MAPK activation of Rnd3 
[334].  Such results implicate B-RafV600E in the promotion of tumor invasion.   
These studies demonstrate several mechanisms through which B-RafV600E drives 
cell cycle progression and survival under tumorigenic conditions.  However, B-RafV600E 
expression and its downstream effectors are not sufficient for transformation to occur.  It 
is widely speculated that loss of tumor suppressors, such as p16INK4a, must accompany B-
RafV600E for tumorigenesis to occur.  My thesis studies demonstrate that B-RafV600E 
causes widespread genomic changes through disregulation of mitosis.  Such a mechanism 
could provide the heterogeneity through which other necessary genomic changes could 
arise. 
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B-RafV600E Expression Drives Mitotic Abnormalities 
B-RafV600E can transform immortalized melanocytes and mouse fibroblasts in 
vitro [216, 223, 225] but how it exerts its oncogenic effects has been an important area of 
study.  Our studies investigated the mitotic effects of oncogenic B-RafV600E in cultured 
human melanoma cells.  Data from these studies show for the first time that B-RafV600E 
induces pleiotropic spindle abnormalities, chromosome misalignment and supernumerary 
centrosomes (Fig. 32).  A high incidence of spindle abnormalities, similar to those 
observed from ectopic expression of the B-RafV600E mutant, were also found in melanoma 
cells carrying endogenous B-RafV600E mutations but not in wild type B-Raf melanoma 
cells (Fig. 31) [335].  Thus, we conclude that oncogenic B-RafV600E abrogates mitosis in 
human melanoma cells.   
The spindle abnormalities induced by B-RafV600E include a high percent of 
multipolar spindles due to cells having 3 or more centrosomes.  As well, B-RafV600E 
causes abnormalities in spindle assembly and chromosome alignment independent of 
centrosomal amplification in approximately 50% of abnormal mitoses.  The mechanisms 
that generate these abnormalities have yet to be defined.  One possibility is that B-
RafV600E deregulates the proteins involved in microtubule capture, thereby leading to the 
observed abnormalities.  Analyzing the mitotic localization and substrates of B-RafV600E 
would shed light on these mechanisms. Like B-RafV600E, expression of oncogenic Ha-ras 
induces mitotic abnormalities in mouse NIH3T3 cells, including multipolar spindles and 
misaligned chromosomes, and it has been proposed that oncogenic Ras deregulates 
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spindle assembly [131].  It is exceedingly rare for Ras and B-Raf mutations to coincide in 
human tumors, therefore suggesting that they elicit overlapping effects. 
In the absence of B-Raf the SAC is not full activated, thus causing early mitotic 
exit and most likely errors in the chromosome segregation.  Consistent with this, recent 
studies from the Guadagno laboratory demonstrated that B-RafV600E signaling promotes 
hyper-activation of the spindle checkpoint causing a delay in mitotic progression [306].  
This is mediated, at least in part, through Mps1, a known target of MAPK signaling.  
Depleting cells of Mps1 by siRNA alleviates the checkpoint effects induced by B-
RafV600E [306].  It is also possible that, due to B-Raf’s uncontrollable high activity, it 
targets unusual substrates, yet to be identified.  Interestingly, published evidence 
indicates that both an under-activated and over-activated SAC compromises the timing 
and quality of chromosome segregation during anaphase leading to generation of 
aneuploid cells [263, 276, 277, 314].  We propose that by over-activating the SAC, 
oncogenic B-RafV600E induces aneuploidy.  In contrast to our studies, oncogenic Ras has 
been shown to shorten a nocodazole-induced SAC in rat thyroid cells, and it does this in a 
MAPK independent manner [231].  These data suggest that oncogenic Ras may regulate 
the SAC through different mechanisms than B-RafV600E. 
   
B-RafV600E Expression Causes Chromosomal Instability 
It is well understood that mitotic errors drive aneuploidy.  Therefore, it was not 
surprising that aneuploidy resulted from the mitotic abnormalities generated by 
introducing the B-RafV600E mutant into SbCl2 melanoma cells (data not shown) and SK-
MEL5 melanoma cells (Figure 32).  Many of the B-RafV600E-expressing cells died, 
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probably due to losses of vital chromosomes.  However, experiments in SbCl2 cells 
showed that many cells continued to survive and proliferate for 4-6 weeks of extended 
culturing.  These cells continued to exhibit abnormal chromosomes numbers that changed 
over time and failed to establish a stable karyotype, as evident by the absence of a 
chromosomal mode (Fig. 35, 36).  Indeed this data is supported by previously published 
findings that induced B-RafV600E expression in rat thyroid cells increases micronuclei 
formation 2-fold, indicating that chromosomes or chromosome fragments are lost during 
mitosis [336].  Interestingly, the vast majority of B-RafV600E-expressing SbCl2 cells were 
hypoploid, the significance of which remains to be addressed.  Hypoploidy is thought to 
arise from loss of chromosomes to micronuclei [337], a result of mitotic abnormalities 
that generate lagging chromosomes.  Oncogenic Ras expression causes lagging 
chromosomes and micronuclei formation in NIH3T3 cells harboring mutant p53 [338] 
and in rat thyroid cells [339], in a MAPK dependent manner.  This suggests that B-
RafV600E and oncogenic Ras generate mitotic abnormalities that lead to aneuploidy.  
However, a role for Ras in mitosis has not been confirmed in human cells. 
The mechanisms by which B-RafV600E drives chromosomal instability have yet to 
be elucidated.  One possibility involves Mps1, a spindle checkpoint kinase identified as a 
potential target downstream of the B-Raf/MEK/ERK signaling pathway [73, 306, 312].  
Mps1 levels are elevated by constitutive B-RafV600E signaling in melanoma cells, which 
allows for hyper-activation of the spindle checkpoint [306].  A hyper-activated spindle 
checkpoint could, in turn, contribute to chromosome segregation errors that lead to 
aneuploidy.  Consistent with this proposal, elevated levels of Mad2 expression are 
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observed in various tumors defective in the Rb pathway [340] and are sufficient to induce 
chromosome instability, aneuploidy, and tumorigenesis in mice [277]. 
It was shown that immortalization itself can indirectly cause aneuploidy [270].  It 
was therefore proposed that aneuploidy-causing agents must induce aneuploidy in pre-
immortalized cells in order to fully meet the criteria as an aneuploidogen [232].  My 
results have shown that B-RafV600E induced aneuploidy in hTERT-immortalized epithelial 
cells (Fig. 38), thereby confirming B-RafV600E as a direct mediator of CIN.  The results 
described here further show that oncogenic B-RafV600E is sufficient to rapidly induce 
aneuploidy in primary human melanocytes (Fig. 37).  Together, these results indicate that 
B-RafV600E-induced CIN could be a mechanism for induction of aneuploidy in both 
melanomas and other human cancers carry activating B-Raf mutations. 
A large proportion (~82%) of benign nevi harbor activating B-Raf mutations 
[220] lending to the idea that B-Raf activation is an early and critical step in the 
development of melanocytic neoplasia.  While genetic evidence supports an early role for 
B-RafV600E in nevi formation [227], sustained B-RafV600E activity is also associated with 
oncogene-induced senescence [341, 342], explaining why most nevi never develop into 
invasive melanomas and remain dormant over long periods of time.  We speculate that 
induction of aneuploidy in proliferating melanocytes creates additional genetic changes, 
which, if tolerated, contribute to melanoma initiation.  This would be in line with several 
reports showing that additional mutations in melanoma susceptibility genes (i.e. p16INK4a, 
ARF, PTEN) are needed to cooperate with oncogenic  B-Raf (or Ras) to allow for 
melanoma initiation [341].  
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Several studies would further help confirm a role for B-RafV600E induced 
aneuploidy in tumorigenesis.  First, karyotypic evaluation of benign nevi harboring the B-
RafV600E mutation would reveal whether the oncogene induces aneuploidy early in 
tumorigenesis.  Since my studies in primary melanocytes and immortalized primary 
epithelial cells demonstrated that B-RafV600E induces rampant aneuploidy after only 2 cell 
divisions, I would predict that some benign nevi are aneuploid.  However, this study 
would have to be conservatively analyzed, since only a minority of benign nevi ever 
proceed to melanomas.  It is perhaps feasible that B-RafV600E induces senescence in the 
majority of nevi, prior to the selection of a large number of aneuploid cells.   
It would also be of interest to determine whether the initial aneuploidy induced by 
B-RafV600E, in human primary melanocytes or immortalized epithelial cells, is sufficient 
for transformation.  These experiments could be conducted utilizing an inducible B-
RafV600E vector, such as an estrogen receptor B-RafV600E-fusion.  Once B-RafV600E 
induces aneuploidy in cells, expression of B-RafV600E could be turned off and surviving 
cells would be selected and grown in soft agar.  It would be predicted that the majority of 
cells would depend to B-RafV600E expression for survival.  However, a minority of cells 
could acquire the proper combination of aneuploidy to become capable of survival and 
colony formation.  Mathematical modeling, such as is available through Moffitt Cancer 
Center’s Integrated Mathematical Oncology group, would be a useful tool in determining 
how well these experiments reflect a clinical model for melanoma progression. 
 
Aneuploidy induced by mitotic errors leads to CIN in nearly all cases reported 
[232].  The effects of CIN cannot be understated as it gives rise to a continuously 
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changing gene expression pattern.  Frequent changes in the genomic profile of cells 
within a population allow for rapid Darwinian adaptation to the intra- and extracellular 
environment.  Thus, selection of the appropriate combinations of CIN can not only drive 
tumorigenesis, but may provide a mechanism for generating cells capable of invasion, 
metastasis and drug resistance.   
 
Relevance for Therapeutics 
 The most common treatment modality for melanomas is tumor resection alone or 
in combination with immunotherapy, chemotherapy or radiation for advanced stage 
disease.  Therapies targeted against B-Raf or B-RafV600E, its oncogenic form, have 
recently been tested in clinical trials, however, most have not shown strong efficacy as 
single agents [343].  Rational efforts have turned toward combination therapies, targeting 
multiple signal transduction pathways or combining B-Raf inhibitors with 
chemotherapeutic agents.  In fact, unpublished data from our lab (not reviewed in this 
thesis) demonstrates that sequential use of placitaxol and a B-RafV600E inhibitor synergize 
to induce caspase-dependent cell death.  Another rational therapeutic strategy employs 
the use of geldanamycin derivatives, since it has been shown that B-RafV600E stability is 
Hsp90 dependent, while WT B-Raf stability is independent of Hsp90 [344].  As with 
other efforts, this appears to be most beneficial in combination with other agents [345]. 
 It is interesting to speculate on how our findings might contribute to the 
development of cancer therapeutics for use against B-RafV600E positive tumors.  Classic 
chemotherapeutic agents and some modern rationally developed drugs target mitosis as 
an effective means of killing cancer cells.  In elegant and elaborate live-imaging studies, 
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it was recently shown that these agents induce mitotic cell death via caspase-dependent 
mechanisms, which are dependent upon a prolonged, cyclin B-induced mitotic arrest 
[346].  Therefore, I would propose that development of agents that stabilize cyclin B 
combined with a caspase activator would synergize with existing drugs in many tumor 
types, including B-RafV600E-positive tumors.  My work and the work of others from the 
Guadagno lab [306, 312] have demonstrated that B-Raf regulates the SAC and that B-
RafV600E generates an extended SAC.  While we have not directly demonstrated that B-
RafV600E stabilizes cyclin B, such stability could enhance the efficacy of 
chemotherapeutic agents, thus arguing against the use of B-RafV600E inhibitors.   
Aneuploidy is another interesting feature of tumor cells that may be useful to 
consider in the treatment of cancers.  Aneuploidy exists in nearly all solid tumors and is 
directly driven in primary cells through B-RafV600E, an early mutation in many tumors.  It 
is reasonable to speculate that aneuploidy-driven intratumoral heterogeneity would 
frequently lead to drug resistance even with the most appropriately targeted therapies.  It 
has recently been proposed that aneuploidy not only drives tumorigenesis, but can be 
protective [263] when aneuploidy drives specific combinations of gene expression.  
While 96 hours of B-RafV600E expression generates viable aneuploid cells, the majority of 
cells are not viable after prolonged expression of B-RafV600E, thus supporting the idea that 
some or most aneuploidy is not tolerated long-term.  Therefore, it may be feasible to 
utilize known aneuploidogens to induce a wide-spread intolerable aneuploidy load in an 
effort to kill tumor cells.     
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Summary 
Mitosis is a complex and critical stage of the cell cycle.  While mitosis has been 
studied for well over a century, the players and the consequences are still being 
elucidated and debated.  Likewise, the cancer biology field has generated volumes of 
data; however, we still have much to learn about tumorigenesis.  B-Raf has been 
identified as an oncogene in a strikingly high number of tumors and it has therefore 
become fundamental to understand how it contributes to cancer.  Through the work in 
this thesis, I have demonstrated that B-Raf is necessary for regulating mitosis, the cell 
cycle stage that maintains the cell’s genomic integrity.  Genomic changes provide cells 
with the capacity to acquire new features and new functions.  It is quite feasible that 
advantageous changes are selected to promote tumor initiation, progression, metastasis 
and drug resistance.  Therefore, our findings that oncogenic B-Raf disregulates mitosis 
and drives genomic instability open a new path for understanding how B-Raf contributes 
to tumorigenesis (Fig. 39).    
  
     
 Figure. 39  Model for B-Raf mediated mitosis 
B-Raf regulates critical mitotic functions which lead to proper chromosomal 
segregation thus maintaining the diploid nature of the daughter cells.  
Contitutively active B-RafV600E disregulates mitosis thereby causing 
missegregation of chromosomes and producing aneuploid daughter cells.  a. B-
Raf regulates the MAPK pathway; B-RafV600E overactives the MAPK pathway; 
b. B-Raf signaling regulates spindle assembly and kinetochore functions 
including microtubule-kinetochore engagement and the spindle assembly 
checkpoint; B-RafV600E disregulates these functions; c.  Proper mitosis leads to 
proper anaphase onset and accurate chromosome segregation; disregulated 
mitosis causes premature anaphase onset and lost and missegregated 
chromosomes; d.  Proper chromosomes segregation generates diploid daughter 
cells whereas missesgregation caused by B-RafV600E renders the daughter cells 
aneuploid.   
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CHAPTER 6 
MATERIALS AND METHODS 
 
Cell Culture and Cell Synchronization 
Human foreskin fibroblasts (HFF), HeLa and NIH3T3 cells were cultured in 
DMEM (Gibco) containing 10% newborn calf serum (Gibco) and 46µg/ml gentamycin.  
Cells were synchronized at G2/M with 50nM taxol in 0.1% DMSO for 30 hours and 
treated with 30µM U0126 or 0.1% DMSO for 6 hours prior to cell collection.  SK-MEL5, 
SK-MEL28, and A375 human melanoma cell lines were obtained from American Type 
Culture Collection (ATCC, Manassas, VA) and maintained in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum (FBS).  SK-MEL5 cells are 
wild type for B-Raf, while SK-MEL28 and A375 cells carry B-RafV600E mutations [216, 
292].  Sbcl2 and WM35 melanoma cells, originally derived from early radial growth 
phase primary melanomas, were obtained previously from M. Herlyn (Wistar Institute, 
Philadelphia, PA).  Sbcl2 and WM35 cells are wild type for B-Raf and were grown in 2% 
tumor media (4:1 mix of MCDB153/L15 media, 2% FBS, 5 μg/ml insulin, 1 mM CaCl2).  
To further confirm the absence of an activating mutation in B-Raf, phospho-ERK levels 
were assessed for SK-MEL5, Sbcl2, and WM35 melanoma cells switched to 0.5% FBS 
for 24 hr.  All three melanoma cell lines exhibited minimal ERK activity whereas SK-
MEL28 and A375 (both containing B-RafV600E mutations) cells showed robust levels of 
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phospho-ERK (data not shown).  Human Mammary Epithelial cells immortalized with 
human telomerase (hTertHME1 cells), were gifted to us by Huntington Potter at the 
Johnnie B. Byrd Alzheimer’s Center and Research Institute at the University of South 
Florida (Tampa, FL).  Cells were cultured in MEGM media from Lonza.  Primary Human 
Epidermal Melanocytes (HEM) were purchased from ScienCell Research Laboratories 
and cultured in Melanocyte Medium from ScienCell.  Primary cells were transfected 
using the Nucleofector system from Amaxa, now part of Lonza, using kits V and NHEM 
for hTertHME1 and HEM, respectively.  Cells were co-transfected with GFP for 
assessment of transfection efficiency.   
 
Transfections and Retroviral infections 
Cells were grown to approximately 70% density in 12-well plates and transfected 
with 21-mer double stranded oligo short interfering RNAs (siRNAs) to human B-Raf 
specific sequences at exon 11 (BE11) [AAAGAATTGGATCTGGATCAT] or exon 3 
(BE3) [AAGCTAGATGCACTCCAACAA] or, to C-Raf specific sequence 
[AATAGTTCAGCAGTTTGGCTA] obtained from Qiagen.  A scrambled siRNA for B-
Raf or C-Raf sequences was used in parallel as a control.  siRNAs were used at 110 nM.  
488λ-conjugated scrambled oligo was used to verify transfection efficiency.  By 48-72 
hours, protein levels for B-Raf or C-Raf decreased 85-95% as confirmed by Western 
blotting. 
pBabe-puro and pBabe-puro-B-RafV600E retroviral vectors were a generous gift 
from Dr. Daniel Peeper (The Netherlands Cancer Institute).  Retroviral vectors were 
transfected into HEK 293T replication-defective packaging cells for retrovirus 
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production.  Melanoma cells were infected with pBabe-puro or pBabe-B-RafV600E 
retroviruses as described and selected in puromycin (0.8 μg/ml) for up to 10 days.  
Puromycin-resistant colonies were pooled and checked for ectopic B-RafV600E expression 
by immunoblot analysis.   
Human melanocytes or hTERT-HME cells were transfected using the 
Nucleofector system from Amaxa. Transfection efficiencies were monitored by 
evaluating green fluorescent cells following co-transfection with pMaxGFP vector from 
Amaxa. 
 
Immunoblot Analysis  
Cells grown in 12-well or 6-well dishes were washed with PBS and scrape-lysed 
in ice-cold TNES buffer containing protease and phosphatase inhibitors (50mM Tris·Cl 
pH 7.4, 1% NP40, 2mM EDTA, 100mM NaCl, 20µg/ml aprotenin, 20µg/ml leupeptin, 
500µM PMSF, 40mM β-glycerophosphate, 500µM Na3VO4, 20mM NaF), incubated on 
ice for 30 minutes and centrifuged for 30 minutes at 14Xg at 4º.  Supernatants were 
analyzed for protein concentrations were determined by a BCA protein assay (Pierce) and 
analyzed by a spectrophotometer (BioRad).  Cell lysates were separated by SDS-PAGE, 
and electrotransferred onto PVDF, 0.45µm membranes.  Membranes were blocked in 5% 
milk/0.15% Tween 20 for 1h at room temperature, incubated with primary antibodies 
against B-Raf and α-tubulin (detailed above), total ERK, C-Raf (BD Transduction labs), 
CAS (BD Transduction Labs), Cyclin B (Santa Cruz) and Beta-actin (Abcam) diluted in 
5% milk/0.15% Tween 20 for 1h at room temperature and washed 3X in 0.15% Tween 
20/PBS.  Membranes were incubated for 1h at room temperature with goat anti-mouse 
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(Jackson ImmunoResearch Laboratories) or goat anti-rabbit (Sigma) alkaline 
phosphatase-conjugated secondary antibodies diluted in 5% milk/0.15% Tween 20, 
washed 4X in 0.15% Tween 20/PBS, incubated for 5 minutes in alkaline phosphatase 
buffer pH 9.5, 5 minutes in CDP-Star chemiluminescence substrate (Roche Diagnostic) 
and exposed to blue sensitive autoradiography X-Ray film (Molecular Technologies).  
Band densitometry data was performed using Image Quant analysis. 
 
Microtubule Depolymerization by Cold Treatment 
For cold-induced microtubule depolymerization, cells transfected with B-Raf or 
control (scrambled) siRNA were grown on coverslips in 35 mm dishes.  Media was 
removed, replaced with ice-cold media, and dishes were subsequently incubated on ice 
for 10 minutes to induce depolymerization of unattached kinetochore-microtubules.  
Cells were then fixed in 4% paraformaldehyde and processed for immunocytochemistry 
as described above.    
 
Nocodazole-Induced Microtubule Depolymerization 
HFF and HeLa cells were grown overnight on coverslips.  Nocodazole was added 
at 125ng/mL (HFF) or 25ng/mL (HeLa) for 2 hours at 37º to depolymerize microtubules.  
Immunofluorescence was performed as described above.   
CSF extracts were generated from unfertilized Xenopus oocytes as described 
below and activated into S-phase using 0.4mM CaCl2 and cycled into a stable mitotic 
state with addition of equal volume of CSF extract.  Reactions were incubated in the 
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presence of 200/µl sperm DNA for 75 minutes at 24ºC to allow for spindle formation 
alone, with DMSO or with 10ng/µl nocodazole. Microtubules were fixed and spun down 
as previously described [115].  The pellet was resuspended in SDS sample buffer, 
separated by 10% SDSPAGE, and immunoblotted for α-tubulin and B-Raf. 
 
Immunocytochemistry  
Cells grown on glass coverslips were fixed at 4º in 4% paraformaldehyde, 
permeabilized with 0.5% triton-X-100 and blocked in 2% BSA.  Alternatively, 
cytoplasmic proteins were solubilized using 1% CHAPS in PHEM buffer containing 
protease and phosphatase inhibitors (60mM Pipes, 25mM Hepes pH 6.9, 10mM EGTA, 
4mM MgSO4, 1µg/ml aprotenin, 1µg/ml leupeptin, 1µM pepstatin, 50mM β-
glycerophosphate, 200µM Na3VO4) for 60 seconds at room temperature, fixed at 4º in 
4% paraformaldehyde and blocked in 2% BSA.  Cells were incubated in 2% BSA for one 
hour with primary antibodies against B-Raf (Santa Cruz or Upstate), α-tubulin (Sigma) or 
Centrin (kindly provided by Jeffrey Salisbury at Mayo Clinic), washed 3X in PBS, 
incubated in 2% BSA for one hour with 488 or 594 Alexa Fluor secondary antibodies 
(Molecular Probes) and washed 3X in PBS.  Cells were mounted with Prolong Gold 
containing DAPI (Molecular Probes). 
To visualize B-Raf at the centrioles, cytoplasmic proteins were pre-extracted 
using 1% CHAPS in PHEM buffer containing protease and phosphatase inhibitors (60 
mM Pipes, 25 mM Hepes pH 6.9, 10 mM EGTA, 4 mM MgSO4, 1 µg/ml aprotenin, 1 
µg/ml leupeptin, 1 µM pepstatin, 50 mM β-glycerophosphate, 200 µM Na3VO4) for 60 
seconds at room temperature, fixed at 4º C in 4% paraformaldehyde and blocked in 2% 
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BSA.  Pre-extracted cells were then incubated with a C-terminal peptide B-Raf 
polyclonal antibody (sc-166) obtained from Santa Cruz Biotechnology (Santa Cruz) and 
co-stained with a mouse monoclonal centrin antibody kindly provided by Jeffrey 
Salisbury (Mayo Clinic, Rochester) to visualize centrioles.   
 
Chromosome Isolations 
 Cells were treated with 1µg/mL colcemid for 2 hours, harvested by trypsinization 
and washed with PBS.  Cells were swollen in 75mM KCL for 10 minutes at 37º and 
subsequently spun onto polylysine coated coverslips at 1800rpm for 8 minutes.  Cells 
were immersed in KCM buffer containing 120mM KCl, 20mM NaCl, 10mM Tris-HCl 
ph7.5, 0.5mM EDTA and 0.1% Triton-X for 10 minutes at room temperature.  
Immunostaining was carried out at room temperature.  Cells were exposed to primary 
antibodies against phospho-B-Raf (Santa Cruz) and CREST (Antibodies Incorporated) 
diluted in 2% BSA in KCM for one hour, washed twice with KCM followed by 488 or 
594 Alexa Fluor secondary antibodies (Molecular Probes) and washed 2X with at room 
temperature.  Immunostaining was performed as described above except BSA and 
antibodies were diluted KCM buffer and cells were washed in KCM buffer followed by 
one final wash with PBS prior to mounting coverslips as described above. 
 
Fluorescence in situ Hybridization (FISH) Analysis and Metaphase Spreads 
 Cells were treated with 1µg/mL colchicine for 2 hours, harvested by 
trypsinization and washed with PBS.  Cells were swollen in 65mM KCL for 5 minutes at 
37º, fixed in cold acetic acid/methanol for 5 minutes at 4º, dropped onto slides and dried 
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at room temperature.  For metaphase spreads, cells were then stained with DAPI and 
viewed with a Nikon E800 fluorescence microscope with a 60x/1.40NA plan apo oil 
immersion objective.  Images were captured with a Roper Coolsnap HQ CCD camera and 
processed with Metamorph 5.0 and Adobe Photoshop 6.0 software.  FISH analysis on 
hTertHME1 and HEM cells were carried out 96 hours post-transfection.  For FISH 
analysis, slides were stained with Cytocell enumeration probes against chromosomes 2 or 
3, and 8 or 10, conjugated with FITC or Cy3.5, respectively (Rainbow Scientific).  
Staining was carried out according to the manufacturer’s protocol.  FISH samples were 
viewed with a fully automated, upright Zeiss Axio- ImagerZ.1 microscope with a 20X 
objective, and DAPI, FITC and Rhodamine filter cubes.  Images were produced using the 
AxioCam MRm CCD camera and Axiovision version 4.5 software suite.  P-values were 
calculated using a 2-sample test for equality of proportions with continuity correction. 
 
Microscopy 
Fluorescent images of mitotic figures were viewed with a Nikon E800 
fluorescence microscope with a 60X/1.40NA plan Apo or 100X/1.3NA plan Fluor oil 
immersion objective.  Images were captured with a Roper Coolsnap HQ CCD camera 
controlled with Metamorph software 5.0, saved as Tif. files, and transferred into Adobe 
Photoshop 8.0 software for final processing.  Phospho-B-Raf images were viewed on a 
fully automated, upright Zeiss Axio-Imager Z.1 microscope with a 63X/1.40NA oil 
immersion objective and images were produced using the AxioCam MRm CCD camera 
and Axiovision version 4.5 software suite.  Confocal images were captured through a 
63X/1.40NA oil immersion objective using a DMI6000 inverted Leica TCS SP5 tandem 
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scanning microscope.  Images and Z-stacks were produced with three cooled 
photomultiplier detectors and the LAS AF version 1.5.1.889 software suite.  Phase 
contrast images of nocodazole-treated HeLa cells were acquired on a Nikon TE 2000-s 
microscope using a 20X objective lens.   
Time-lapse live imaging of HeLa cells was performed with an inverted Nikon 
TE2000-S using a 20X 0.4NA Ph1 phase lens (Nikon).  An FCS2 closed chamber system 
(Bioptechs, Inc., Butler, PA, USA) was used to infuse media and CO2 at a rate of 5 mL 
per hour.  Phase-contrast images were captured once per minute using a Retiga 1300 
(QImaging Corporation, Canada) camera and IPLab 3.61 (BD Biosciences) software.  
Images were saved individually as Tif. files and incorporated into Image Pro Plus 6.2 
(Media Cybernetics, Inc) to generate sequence file time lapse movies.  The mass 
projections were 16 images taken through the Z dimension every 0.4um.  Images were 
projected over one another in Maximum Projection to illustrate depth of field through the 
cell.  The signal was enhanced using opacity (transparency) to demonstrate colocalization 
between B-Raf and microtubules. 
The CENP-E, CREST mass projection was rendered 360 degrees around the y-
axis to display colocalization in all 3 dimensions (x, y, z).  For CENP-E, CREST 
colocalization, Samples were viewed with a Leica DMI6000 inverted microscope, TCS 
SP5 confocal scanner, and a 63X/1.40NA Plan Apochromat oil immersion objective 
(Leica Microsystems).   405 Diode, 488 Argon, and 594 HeNe laser lines were applied to 
excite the samples and tunable filters were used to minimize crosstalk between 
fluorochromes.  Image sections at 0.5 µm were captured with photomultiplier detectors 
and prepared with the LAS AF software version 1.6.0 build 1016 (Leica Microsystems).  
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Images of colocalized pixels were prepared with LAS AF software and analyzed for 
CENPE intensity using Image Pro Plus 4.5 (Media Cybernetics, Maryland).   
The Imaris deconvolution images were created by processing z stack images 
generated by the confocal microscope through AutoDeblur deconvolution software 
(Mediacybernetics Inc.) using default settings.  The resulting z-stack images were then 
imported into Imaris version 5.5 (Bitplane Inc.).  3D isosurface renderings were created 
by adjusting the intensity thresholds for each color channel. 
 
Spindle Assembly in Xenopus Egg Extracts 
Cytostatic factor (CSF) arrested extracts were prepared from unfertilized Xenopus 
eggs and spindle assembly reactions were preformed as described [347], except that 
extracts were cycled into mitosis using recombinant nondegradable cyclin B (75 nM 
final).  Rhodamine-labeled bovine brain tubulin (Cytoskeleton) was added to a final 
concentration of 0.15 µg/µl in extracts to visualize microtubules.  B-Raf (Santa Cruz) or 
IgG control (Sigma) antibodies were used for immunodepletions from CSF extracts prior 
to their activation and cycling.  To monitor spindles and associated chromosomes, 2 µl of 
extract and 1 µl of Hoechst/fixative (25% glycerol, 7.4% formaldehyde, 0.1 mM Hepes 
pH 7.5, 4 µg/ml bisbenzimide) were applied to a microscope slide and examined by 
immunofluorescence. 
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